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ABSTRACT 
 
 The Periplasmic Nitrate Reductase (Nap) from Cupriavidus necator (Cn) belongs 
to the Dimethyl Sulfoxide (DMSO) Reductase family of mononuclear Mo-containing 
enzymes and catalyzes the reduction of nitrate to nitrite. The protein comprises a large 
catalytic subunit containing the Mo active site and one [4Fe-4S] cluster (NapA, 91kDa), 
and a small diheme c-type cytochrome subunit (NapB, 17kDa). In the present dissertation, 
the reaction mechanism of the Periplasmic Nitrate Reductase from Cupriavidus necator is 
studied by X-Ray Crystallography and complementary techniques like Thermal Shift 
Assays (TSA), Isothermal Titration Calorimetry (ITC) and Microscale Thermophoresis 
(MST). 
In the first crystallographic studies of Nap from Desulfovibrio desulfuricans (Dd), it 
was established that in the active site, the Mo atom was coordinated by two cis-dithioline 
groups, a sulfur from a cysteine side chain and a water/hydroxo ligand. Recently published 
crystal structures of Nap, particularly the structure of the heterodimeric Cn NapAB solved 
at high resolution (1.5 Å) and Dd NapA with bound ligands demonstrated that the sixth 
ligand is in fact a sulfur atom, contrary to the previous believed water/hydroxo ligand. Also, 
a partially reduced NapAB Cn crystal structure was obtained, where the coordinating Mo 
Cys thiolate is partially occupying a new conformation. The sixth sulfur ligand seems to 
have a partial disulfide bond with the Cys thiolate group, blocking nitrate from interacting 
directly with the Mo atom unless some rearrangement occurs during catalysis. 
Various crystal structures of NapAB from Cn co-crystallized with ligands are presented 
in this dissertation complemented by TSA, ITC and MST results. The results corroborate 
the existence of an alternate conformation of the coordinating Mo Cys thiolate and pave 
the way for more studies about the reaction mechanism of nitrate reductases. 
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RESUMO 
 
A nitrato reductase periplasmática (Nap) de Cupriavidus necator (Cn) pertence à 
família da Dimetil Sulfóxido (DMSO) Redutase de enzimas mononucleares de Mo e 
catalisa a redução de nitrato a nitrito. A proteína contém uma grande subunidade catalítica 
que contém o centro ativo de Mo e um centro [4Fe-4S] (NapA, 91kDa) e uma pequena 
subunidade de citocromo dihémica tipo c (NapB, 17kDa). Na presente dissertação, o 
mecanismo de reacção da nitrato redutase periplasmática de Cupriavidus necator é 
estudada por Cristalografia de Raios-X e técnicas complementares como “Thermal Shift 
Assays” (TSA), “Isothermal Titration Calorimetry” (ITC) and “Microscale Thermophoresis” 
(MST). 
Nos primeiros estudos cristalográficos da Nap de Desulfovibrio desulfuricans (Dd), 
estabeleceu-se que no centro ativo o átomo de Mo seria coordenado por dois grupos cis-
ditiol, um enxofre de uma cadeia lateral de cisteína e um ligando água/hidroxilo. As 
estruturas cristalinas recentemente publicadas de Nap, particularmente a estrutura do 
heterodímero NapAB de Cn a alta resolução (1.5 Å) e Dd NapA com ligandos, 
demonstraram que o sexto ligando de Mo é de fato um átomo de enxofre, ao contrário do 
ligando de hidroxilo / água anteriormente estabelecido. Além disso, obteve-se uma 
estrutura da NapAB de Cn parcialmente reduzida, onde o grupo tiolato da cisteína que 
coordena  o Mo Cys está a ocupar parcialmente uma nova posição. O sexto ligando de 
enxofre parece ter uma ligação parcial de dissulfureto com o grupo tiolato da cisteína, 
bloqueando o nitrato de interagir diretamente com o átomo de Mo, a menos que ocorra 
algum rearranjo durante a catálise. 
Várias estruturas cristalinas da NapAB de Cn co-cristalizadas com ligandos são 
apresentadas nesta dissertação complementadas pelos resultados de TSA, ITC e MST. 
Os resultados comprovam a existência de uma conformação alternativa da cisteína que 
coordena o Mo e abre caminho para mais estudos sobre o mecanismo de reação das 
nitrato redutases.
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1 INTRODUCTION 
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1.1 MOLYBDENUM ENZYMES AND THE PYRANOPTERIN COFACTOR 
Molybdenum (Mo) is a transition metal incorporated in more than 50 known 
enzymes and is essential to almost all known forms of life. Organisms that do not 
dependent on this element use tungsten (W) instead, which has similar chemical 
characteristics.  [1], [2]. 
Molybdenum is a versatile element that is able to coordinate from 4 up to 8 ligands, 
varying in oxidation states from -2 to 6, being oxidation states IV to VI the most stable 
while bonded to biologic macromolecules. This flexibility in oxidation states allows it to 
act as transducer between obligatory two-electron and one-electron oxidation-
reduction systems [1]. Mo is mainly available in seawater as molybdate (MoO42-) and 
is found either in the multinuclear MoFe7 (bacterial nitrogenases) or mononuclear 
(bond to one or more pterin cofactor) forms [3], [4]. 
Mononuclear Mo enzymes possess a tricyclic pterin (or pyranopterin) cofactor, 
originally named Moco (Molybdenum Cofactor) and it was first discovered in xanthine 
dehydrogenase (XDH) and nitrate reductase (NR) enzymes. Only later it was found 
that it also binds tungsten. Mo is found coordinating the dithiolene group of either one 
(xanthine oxidase and sulfite oxidase families – XO and SO respectively) or two 
(dimethyl sulfoxide reductase family - DMSO) pyranopterins. Besides binding to the 
pyranopterin, Mo is also found coordinated to terminal oxo/hydroxo groups, sulfide 
groups and amino acid residues side chains through different combinations. Based on 
the Mo ligands, spectroscopic and biochemical data, pyranopterin-dependent 
enzymes have been divided into three families: the xanthine oxidase (XO), the sulfite 
oxidase (SO) and the DMSO reductase families (Figure 1.1.a). In the XO and SO 
families, only one pyranopterin coordinates the Mo atom. Additionally, in the XO family 
the Mo is found coordinating a hydroxyl group, one oxygen and a sulfur while in the 
SO family Mo binds to one hydroxyl group, an oxygen and to the side chain of a 
cysteine. In the DMSO reductase family two pyranopterins coordinate the Mo atom 
which also coordinates one hydroxyl or thiol groups, oxygen or sulfur atoms and the 
side chains of: cysteine, selenocysteine, aspartic acid or serine [5].  DMSO is the most 
diverse family and is further divided into three subfamilies as depicted in Figure 1.1.a. 
[3], [5], [6]. 
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The pyranopterin is expected to be responsible for the correct positioning of the Mo 
atom in the catalytic center, to control its redox behavior and to participate in the 
electron transfer to or from the Mo. The cofactor is found deeply buried within the 
protein and whenever it is released from the enzyme, it undergoes rapid degradation 
due to oxidation reactions [3], [5], [6].  
The pyranopterin biosynthesis is a conserved pathway that can be divided into four 
steps (Figure 1.1.b) [7]: I – Conversion of GTP (Guanosine Triphosphate) into the 
Precursor Z, the most stable intermediary; II – Sulfur transfer to precursor Z, catalyzed 
by MPT (Metal Containing Pterin) synthase; III – MPT adenylation producing the ready 
to bind Mo (or W) (this process is catalyzed by two proteins in bacteria whereas in 
higher organisms both were fused into a two-domain protein - Cnx1); IV – Mo insertion 
Figure 1.1: Pyranopterin Dependent Enzyme Families and the Moco Biosynthesis. 
a) Pyranopterin dependent enzyme families and the DMSO reductase sub-families (adapted from 
Romão 2009 and Coelho & Romão 2015). b) Proposal for the eukaryotic Moco biosynthesis (adapted 
from Mendel 2006). Abbreviations: XO/XDH – Xanthine Oxidase/Dehydrogenase; CODH – CO 
Dehydrogenase; SO – Sulfite Oxidase; SDH – Sulfite Dehydrogenase; Nas – Assimilatory Nitrate 
Reductase; Fdh – Formate dehydrogenase; Nar – Membrane bound Respiratory Nitrate Reductase; 
Nap – Periplasmic Nitrate Reductase; EBDH – Ethylbenzene Dehydrogenase; TMAOR – 
Trimethylamine Oxide; GTP – Guanosine Triphosphate; MPT – Metal Containing Pterin; AMP – 
Adenosine Monophosphate. 
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preceded by a copper atom exit which is thought to preserve the pathway 
intermediaries from unintended oxidation [3].  
In prokaryotes, the pyranopterin is found conjugated to nucleosides whereas in 
eukaryotes it is in the monophosphate form. Lack of the cofactor synthesis may lead 
to a decrease or loss of the Moco-enzymes functions in the organism. In humans, it 
leads to mental retardation and attenuated brain growth followed by death, due to 
deficiency in SO activity [3], [5]. 
Note that eukaryotic NR are part of the SO family and are not under the scope of this 
dissertation. 
1.2 NITRATE REDUCTASES 
1.2.1 Biologic and Ecologic Context 
Nitrogen is the fourth most abundant element in the biosphere and is the nitrogen 
cycle that delivers and recycles this essential element throughout the Ecosystem. Nitrogen 
is involved in many anabolic and catabolic pathways where it can be incorporated into 
amino acids and nucleic acids or be part of respiration processes. Due to human activities 
like the overuse of nitrate based fertilizers, the nitrogen cycle “has been altered more than 
any other basic element cycle” [8]. 
Nitrate is the most stable and important nitrogen source in soils and water, reduction 
of nitrate to nitrite - a key step in the nitrogen cycle – becomes therefore important in the 
management of the ecosystem. This reaction is catalyzed by nitrate reductases (NR) and 
is the first step in both assimilatory and dissimilatory nitrate reduction pathways [9].  
Prokaryotic nitrate reductases belong to the DMSO reductase family of Mo containing 
enzymes and their functions and localizations vary between nitrogen assimilation 
(cytoplasmic nitrate reductases - Nas), energy generation (membrane bound nitrate 
reductases - Nar) and excess energy dissipation (periplasmic nitrate reductase - Nap) [10]. 
The cytoplasmic assimilatory nitrate reductase (Nas), catalyze the first step of nitrogen 
assimilation and receive electrons from nicotinamide adenine dinucleotide (NADH), 
reduced nicotinamide adenine dinucleotide phosphate (NADPH), ferredoxin, or flavodoxin. 
Respiratory nitrate reductases (Nar) are membrane-bound (facing the cytoplasm) 
enzymes that obtain the reductive power from periplasmic formate, whose electrons are 
transferred through the quinone pool to the Nar active site, releasing nitrite into the 
cytoplasm and contributing to the proton motive force [10], [11].  
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The true physiological role of periplasmic nitrate reductase (Nap) is not yet fully clear. 
Periplasmic nitrate reductases are known to be responsible for the redox balancing but 
they are also involved in the denitrification process, nitrate scavenging and respiration, 
even though apparently, they do not contribute for the proton motive force. Electrons 
originating from the quinone pool flow through the tetra-heme monomer NapC, passing by 
a di-heme monomer NapB, reaching the active site in NapA [10]. The catalytic subunit 
NapA ranges from 70 kDa (D. desulfuricans) to 90 kDa (C. necator) and some organisms 
like D. desulfuricans lack the NapB monomer [4], [10]. 
Nitrate reductases have been implicated in a diverse range of functions, namely 
denitrification, reduction to ammonia, maintenance of cellular redox potential, nitrate 
respiration and scavenging. Because these functions are so diverse, knowledge about NR 
activity in the ecosystems becomes an important step towards the regulation of the 
nitrogen cycle. Through better understanding these enzymes we can better predict the 
impact on biodiversity, global warming and water quality – essential problems caused by 
the gradual disruption of the nitrogen cycle [8], [9]. 
1.2.2 Structure of Periplasmic Nitrate Reductases: State of the Art 
The first structure of a NR was solved by X-Ray Crystallography in 1999 ([12]. The 
protein is a monomer isolated from Desulfovibrio desulfuricans (Dd) and the structure was 
obtained at 1.9 Å resolution. At the time, the model was published with six Mo ligands, four 
provided by the cofactor cis-dithiolene groups, one from the side chain of a cysteine and 
the sixth was interpreted as an oxo/hydroxyl ligand. The model showed a distorted trigonal 
prismatic geometry involving Mo and its ligands [12]. The first crystal structure of a 
heterodimeric NR (NapAB from Rhodobacter sphaeroides) was obtained in 2003 at 3.2 Å 
resolution [13]. In 2007 the crystal structure of the catalytic subunit NapA from Escherichia 
coli was obtained at 2.5 Å. During purification the NapB monomer would dissociate and 
therefore its structure was not determined in the study [14].  
New crystallographic studies of novel Dd NapA structures were later conducted of 
the protein in the native state and with ligands, with resolutions between 1.99 Å to 2.50 Å. 
Through improved refinement methods, this work showed that the sixth Mo ligand is a 
sulfur atom instead of oxygen. The authors also highlighted the proximity between the fifth 
and sixth ligands, implying a partial disulfide bond. Due to the true nature of the sixth 
ligand, the initial proposed reaction mechanism (based on oxygen chemistry) needed to 
be revisited and more research was therefore required [15].  
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Figure 1.2: Structure of NapAB from Cupriavidus necator. 
The cartoon colors represent the various NapA domains and the NapB monomer: domain I, 
green; domain II, red; domain III, sand; domain IV, blue; NapB, magenta. A zoom in of the NapAB 
active site cofactors and electron pathway is shown (rectangle); Zoom in of the active site of 
NapAB is also shown (circle). 
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The crystal structure of the heterodimeric NapAB from Cupriavidus necator (Cn), 
was solved at atomic resolution (1.5 Å) and corroborated that the sixth Mo ligand was a 
sulfur atom [16]. The authors also published a partially reduced NapAB structure which 
showed the Mo coordinating cysteine with a novel alternate conformation, further 
advancing the discussion on the Nap reaction mechanism.  
The NapAB from Cn is a globular heterodimer of an approximate dimensions of 65 
Å x 65 Å x 58 Å and is shown in Figure 1.2. The larger subunit, NapA is composed of 802 
amino acids and is responsible for catalyzing the reduction of nitrate to nitrite. This 
monomer contains the Mo atom bound to two molybdopterin guanosine dinucleotide 
(MGD) cofactors and a [4Fe4S] cluster involved in electron transfer. The active site is 
buried within the protein, having a 15 Å long substrate channel leading to it in the opposite 
side of the interface between NapA and NapB. The NapB monomer is responsible of 
transporting electrons originating from the quinone pool and NapC (a membrane-anchored 
tetraheme c-type of unknown structure), towards NapA. NapB has 134 amino acids and 
contains two c-type hemes – with two histidines coordinating the iron atoms. The electrons 
reaching the active site originating from the heme groups (10 Å away from each other), 
are expected to be mediated by the conserved NapA tyrosine 58 (8 Å away) that is at the 
interface between NapA and NapB and reaching the [4Fe4S] cluster (also 8 Å away). From 
the [4Fe4S] cluster, the electrons should first pass through the highly conserved NapA 
lysine 56 (4 Å away) and finally reach the nearest MGD cofactor that is 3 Å away. The 
NapA from Cn is organized in 4 domains: I – residues 4–68, 507–531, and 600–641; II – 
residues 69–148, 386–506, and 532–599; III residues 149–385; and IV residues 642–802. 
The N-terminal domain (I) contains the four cysteine residues coordinating the [4Fe4S] 
cluster, domains II and III have an overall similar α/β fold and each one binds one of the 
two MGD cofactors. The domain IV is a β-barrel and is very exposed to the solvent. 
1.2.3 Proposed reaction mechanism and its considerations 
Based on the Mo chemistry and the nature of the sixth ligand, three alternative 
reaction mechanisms where initially proposed [15], [17], [18]. These hypotheses can be 
differentiated by the combination of two aspects – substrate direct/indirect binding to Mo 
and preservation/breaking of the Mo-fifth ligand: (Figure 1.3.a) Substrate direct binding to 
Mo and breaking of the bond between Mo and its fifth ligand; (Figure 1.3.b) Substrate 
second-sphere coordination to the Mo ligand; (Figure 1.3.c) Substrate direct binding to 
Mo. [17]–[21] 
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The proposed reaction mechanism also states that the formation of bonds and/or 
partial bonds between the fifth and the sixth sulfur ligands plays a role in the redox state 
of molybdenum. This is corroborated by the different crystal structures where the distances 
vary between 2.17 Å and 2.80 Å – where the van der Waals contact distance is 3.3 Å [4], 
[15]. 
Figure 1.3: NapAB proposed reaction mechanism. 
a-c (adapted from Najmudin et al., 2008): the various considered possibilities for the substrate 
interaction with the active site. a) Substrate direct binding to Mo and breaking of the bond between 
Mo and its fifth ligand; b) Substrate second-sphere coordination to the Mo ligand; c) Substrate direct 
binding to Mo. d) the proposed reaction mechanism for Nap [17]–[21]. 
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Independent studies involving computational chemistry were also performed. In all 
cases the authors concluded that a first coordination sphere mechanism where the 
cysteine remained indirectly bound to the Mo atom was energetically more favorable [17], 
[18].  
The proposed mechanism implies that for the enzyme to become active, a 
conformational rearrangement must first occur (Figure 1.3.d). This rearrangement 
involves the Mo coordinating cysteine changing from a first coordination shell to a second 
coordination shell ligand. The cysteine’s side chain loses its Mo bond and starts bonding 
to the sixth ligand, which in turn shifts towards the fifth ligand’s prior position. From this 
rearrangement originates a free Mo coordinating position where the substrate may bind 
[4], [22]. After substrate binding, catalysis follows and an oxygen atom is left bonded to 
Mo. For the active site regeneration two electrons and protons are transferred to the 
remaining oxygen and a water molecule is released. The catalytic cycle continues until 
nitrate is consumed and the inverse of the sulfur shift occurs. 
A partially reduced NapAB structure from Cn was obtained at 1.7 Å resolution [16]. 
During refinement of this structure, the Mo coordinating cysteine (Cys 152) presented extra 
positive electron density near the Cβ. The authors interpreted this new density as a 
cysteine alternate conformation with 12% occupancy. The mechanism hypothesis 
previously described is corroborated by this structure. The conformational freedom of the 
active site, the bond and/or partial bond interaction of the fifth and the sixth sulfur ligands 
with the subsequent computational chemistry studies sustains the proposed mechanism. 
However further studies are necessary to establish the NR reaction mechanism [17]–[21]. 
1.3 X-RAY CRYSTALLOGRAPHY 
 Macromolecular X-Ray Crystallography is a technique used to solve the 3-D 
macromolecular structures up to atomic resolution. This technique takes advantage of the 
crystal high degree of organization and the X-ray characteristics – the wavelength range 
compatibility to the atomic bonds and the diffraction pattern of the electrons [23]. 
 This technique is used worldwide and its major drawback are the difficulties in 
obtaining crystals. X-Ray Crystallography was the first technique to deliver atomic 
resolution structures and is until today the most used technique for such purposes. By 
August 2017, the protein data bank (https://www.rcsb.org/pdb/statistics/holdings.do) 
holded 132428 structures from which 118533 (90 %) were provide by X-Ray 
Crystallography. Other available structural biology techniques are Nuclear Magnetic 
Resonance (NMR), Cryo-Electron Microscopy (Cryo-EM) and Small-angle X-ray 
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scattering (SAXS) that possess different sets of advantages/drawbacks. X-Ray 
Crystallography, NMR and Cryo-EM can be used in separate to produce detailed 3-D 
structures or may also be combined, complementing each other to succeed in particular 
cases. 
1.3.1 Protein crystallization 
The crystallization of proteins is a procedure which relies on diverse ways of 
gradually increasing the protein concentration. The event must be slow and gentle 
enough so that the proteins precipitate in an organized manner, leading to the 
formation of crystals. Crystals are highly organized matter and can be represented by 
the unit cell – the smallest group of molecules that can reconstruct the crystal by 
symmetry operations. Unit cells are characterized by the length of “a”, ”b”, and ”c” and 
the “α”, “β” and “” angles between them [23]. Unit cells contain at least one 
asymmetric unit, which reconstructs the unit cell by symmetry operations and belong 
to one of four types: Primitive lattice (P), base-centered lattice (A, B or C), internal-
centered lattice (I) or face-centered lattice (F). When combined with the seven 
crystalline systems, 28 crystalline lattices are available. Since proteins are chiral, the 
symmetry operations available are translation and rotation, excluding any mirror 
planes or inversion centers.  Because of this, the possible space groups for protein 
crystals are reduced from 230 to 65, all of them available for consult at “The 
International Tables for Crystallography”. Protein crystals contain water channels 
which represent 30-70% of the crystal as first described by Matthews [23], [24]  
 Protein crystals are used to diffract X-rays. Planes of atoms within the crystals act 
as X-Ray reflectors through constructive interferences serving as signal amplifiers. 
The diffraction of unorganized atoms within the crystal will cause destructive 
interference, whereas diffraction from the organized atoms will be recorded in the 
diffraction patterns [23]. 
1.3.1.1 Phase Diagrams and the Crystallization Process 
  Phase diagrams may be composed of various zones, namely precipitation, 
nucleation and crystal growth and represents the crystallization process for each 
unique protein (Figure 1.4). For maximizing the probability of obtaining adequate 
crystals, the crystallographer attempts to obtain a solution that conveniently passes 
through the three stages in. The objective is to start in the unsaturated zone (Figure 
1.4.a). As water moves out of the crystallization droplet, the protein and the 
precipitants concentration increases because the water volume is reduced. In theory, 
as the protein and precipitant concentration arise, the crystallization droplet changes 
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from the unsaturated stage, to the nucleation stage (Figure 1.4.b). The droplet passes 
by the crystal growth stage because here it cannot form new nuclei and there are not 
existing nuclei to grow. When the nucleation stage is reached, the protein begins to 
form crystal nuclei, so its concentration starts to decrease. As the protein 
concentration lowers, the droplet changes towards the crystal growth stage again 
(Figure 1.4.c). When this stage is achieved, the already formed nuclei continue to 
grow, forming crystals. The crystals will grow until the solution reaches equilibrium or 
is perturbed [23], [25]. 
This is a complex and not yet fully understood phenomenon, often needing fine-
tuning of key conditions. Because of this, and the fact that so many (non-exhaustively 
testable) conditions vary on significance for each protein to be crystallized, the 
crystallization step is still partially empiric [23]. 
1.3.1.2 Crystallization Methods 
There are several crystallization methods, ant the most common is the vapor 
diffusion method, which can be performed by the hanging or sitting drop techniques. 
In hanging drop, the crystallization condition containing the precipitating agent is 
applied on the top of a silanized cover slip and the protein is added, followed by sealing 
of the well with the cover slip. Since there is a lower precipitant concentration in the 
drop, water slowly diffuses into the reservoir. In the sitting drop method the drop 
Figure 1.4: A protein crystallization phase diagram.  
In the diagram is shown a hypothetical crystallization condition progress along time (brown 
circles). The protein droplet passes by the crystal growth zone (a-b) reaching the nucleation 
zone (b). Here crystal nucleus are generated and start to grow, lowering the dissolved protein 
concentration. The droplet leaves the nucleation zone, passing the remaining time in the crystal 
growth zone. The crystals grow until no more protein is available, hence reaching the interface 
between the crystal growth and unsaturation zone (c). 
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containing the precipitant/protein  is placed in a small platform inside the well (Figure 
1.5) [23]. 
Other methods used in protein crystallography are dialysis and micro batch. The 
first consists in a small button enveloped by a dialysis membrane and immersed in the 
crystallization condition. The dialysis button has a depression where the protein is 
previously added, therefore, protein-crystallization solution contacts are made only 
through the dialysis membrane. The micro batch is a technique that makes use the 
protein and water insolubility in oil. In this technique, the protein and crystallization 
solution are added to oil in the bottom of the well as a single drop. Water will migrate 
from the drop to the oil at an even slower rate than for instance, vapor diffusion [23].  
The use of crystallization robots for automated crystallization is a popular and 
appealing option. Crystallization robots are used for initial screening assays. Using 
special crystallization plates, the robots automatically add the protein and 
crystallization solutions to the wells. The machines complete the screening assays 
much faster, but also use significantly less protein amounts (down to the nano-scale) 
that humans are able to. The major downfalls of the robots is that the crystals are 
usually smaller and a scale up is required, which might be complex and problematic 
in specific cases [23], [26]. 
1.3.1.3 Co-crystallization, Soakings and Cryoprotectant Solutions 
Proteins in the crystalline form may retain their function and tolerate some 
conformational changes induced by ligands without damaging the crystal [23], [25], 
[27]. Besides structures of site-specific ligand interaction with the proteins, important 
Figure 1.5: Representations of the principle vapor diffusion method techniques: 
hanging drop, sitting drop and microbatch. 
A simple representation of the three crystallization methods used in this work. The dashed arrows 
represent the movement of water from the protein drop to the reservoir. a) Hanging drop; b) sitting 
drop; c) microbatch. 
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conformational changes caused by the ligands can be revealed. For this purpose, 
several procedures such as co-crystallization or soakings experiments can be made.  
Co-crystallization consists in crystallizing the protein while the ligand is dissolved 
in the crystallization drop, either by previously incubating the protein with the ligand, 
or by adding the ligand to the protein drop during the crystallization. Soaking 
experiments consists in introducing new solutions that contain the ligand in pre-
existing crystals. The ligand diffuses through the water channels within the crystal and 
interact with the protein molecules. If drastic conformational changes are expected, 
co-crystallization might be preferable to avoid crystal damage. 
After the crystals are grown, they can be transferred to stabilizing and 
cryoprotectant solutions for diffraction experiments. In order to prevent the crystals 
from dissolving, the solutions used possess higher precipitating agent concentrations 
than in the conditions that they grew. During the diffraction experiments or transport, 
liquid nitrogen (-197 ˚C boiling temperature) is used. Aiming to avoid the water within 
the crystals to freeze and damage them, cryoprotectant solutions are used. The 
cryoprotectant solutions possess a cryoprotectant agent that inhibits the formation of 
water crystals. For these purposes glycerol, xylitol, sugars, Polyethylene Glycol 
(PEG), salts or mixtures of these are used [23]. 
1.3.2 X-Ray Sources 
The first generation of X-Ray sources were the X-Ray tubes, in which electrons 
collided with an anode under vacuum conditions. In these conditions, when the electrons 
hit the metal, inner orbital electrons are ejected from it. An outer orbital electron then fills 
the empty orbital and releases energy in the form of X-rays. Each metal emits photons in 
varying specific wavelengths. However, this procedure heavily degrades the metal in the 
zone that the electrons collide. To solve this problem, other X-Ray sources were invented 
– the rotating anode X-Ray tubes. In this case the anode was rotating and the area of 
impact of electrons was distributed along the anode. By doing this, the degradation of the 
anode was dispersed in a larger area. Although, the temperature rise under vacuum 
conditions did remain a problem [23].  
Synchrotron radiation is widely used nowadays. Electrons are accelerated in 
storage rings to near the speed of light and emit X-Ray photons when forced to change in 
direction but continue to accelerate. The photons released pass through monochromators 
that make X-Ray wavelength selection possible. Synchrotron radiation further 
revolutionized X-Ray crystallography in the drastic time reduction required for data 
collection, data quality and crystal size requirement [23]. 
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A more recent X-Ray source is the Free Electron Laser X-Ray (XFEL), where the 
electrons are instead accelerated in a straight line. This technology produces extremely 
brilliant and short pulses. Because of this, data can be collected free of radiation damage 
– the radiation pulse exits the sample faster than the damage occurs [28]. 
1.3.3 Protein crystal diffraction 
In the diffraction experiment X-rays go through a protein crystal and are diffracted by 
the electrons of the protein. The diffracted beams hit the detector and its intensities and 
relative positions are recorded. Although the phase information is not detectable and 
therefore lost. The experiment results in a diffraction pattern, a plane with various spots 
varying in size proportionally to photon count. The crystal orientation is changed over the 
course of the diffraction experiment, obtaining thousands of diffraction patterns, reflected 
from the different lattice planes of the crystal. The diffraction patterns are indexed forming 
a hypothetical 3D diffraction pattern sphere (Figure 1.6.a). The result of the experiment is 
a list of intensities across the reciprocal space sphere and correspondent errors [23].  
Since the crystal is a periodic organization of molecules, some atoms diffract in the 
same direction and in phase with each other in all the unit cells which constitute the crystal. 
These atoms are said to diffract X-rays in a constructive manner, increasing its signal 
proportionally to the number of such atoms. In contrast atoms not structurally repetitive 
inside the crystal (as for solvent channel’s waters) give diffractions varying in direction and 
phase that cancel each other [23]. W.H. Bragg and his son W. L. Bragg discovered and 
mathematically described this phenomenon now known as the Bragg’s Law (Figure 1.6.b). 
The planes of atoms within a crystal that produce constructive diffraction can be 
represented by three numbers, called the Miller indices (or lattice indices) – h,k and l. 
These indices represent sets of parallel planes with constant interplanar spaces of dhkl. If 
the scattered waves from X-rays are in phase, they interfere constructively. When these 
conditions are met, constructive interference happens, resulting in multiple 
diffracted/reflected X-rays in the same direction and in phase – a strong diffracted beam 
that produces a spot in the diffraction pattern. Each crystal orientation has a different 
number of sets of planes that meet the Bragg’s law condition. The crystal is rotated in order 
to capture the diffraction of more planes of atoms [23]. 
For diffraction data evaluation, various parameters are used in combination. Some of 
the more used parameters and its expected values are: Ratio of signal to noise (I/σ(I)) 
(should be no less than 2); completeness, which represents the percentage of measured 
expected reflections (should be above 95% at the highest resolution shell); 3); correlation 
coefficient (CC1/2) representing the correlation between two halves of a randomly split data 
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set (should be no less than 0.5); 4); and Rmerge which is the averaging of multiple symmetry-
related reflections, depending on the study case a value lower than 0.25 is acceptable 
[23]. 
1.3.4 The Phase problem 
Fourier showed that any complex periodic function can be described as the 
sum of simpler periodic functions. Diffracted X-rays can be described as three-
Figure 1.6: Schematic representation of the diffraction experiment and constructive 
interference.  
a) X-rays go through a Nap crystal which results on a diffraction pattern. As the crystal rotates more 
diffraction patterns are collected that forms a hypothetical reciprocal diffraction sphere. Symbolizing 
the unit cells are Nap structures. The crystal photo, diffraction pattern and NapAB structures have 
all been experimentally obtained during the course of this work. b) Constructive interference is 
produced from sets of planes (horizontal dashed lines) of atoms (yellow dots), with interplanar 
spaces of dhkl, from impinging X-rays of wavelength λ with a θ angle only if Bragg’s law is met. To 
the right a simple description of the relation between interplanar spacing and difference in path 
length of X-Rays 1 and 2 (adapted from Rhodes 2007). 
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dimensional waves, they are therefore a complex periodic function and can be 
described as the sum of various simpler functions [23]. 
 The 3D electronic distribution of the atoms in the protein can be calculated using 
the Fourier Transform (FT). The FT transforms the values of a periodic function in their 
reciprocal values, in the case of X-Ray Crystallography it transforms the reflection data 
(reciprocal space) into electron density data (real space). FT is reversible, therefore 
applying it to electron density data gives back the reflection data [23]. 
 The FT requires the amplitudes and phase angles to transform diffraction data into 
real space information. Amplitudes are calculated directly from the indexed list of 
reflection intensities experimentally obtained. The phase angles are however missing, 
resulting in the “phase problem” where the crystallographer needs to obtain phase 
information by other means [23]. Molecular replacement is one way of obtaining phase 
information. It is popular and widely used because it does not require any additional 
experiments, but does require an already existing homology model of the protein in 
study. The method consists in placing the already obtained structure into the new unit 
cell. After translation and rotational operations, the phases of the X-rays this structure 
would diffract are calculated. These phases are taken as initial estimations of the real 
unattained phases [23], [25]. 
1.3.5 Model Improvement 
 With the estimated phases and the measured intensities, the FT is applied and a 
3D description of the protein electronic distribution is obtained. This model is however 
greatly influenced by the model used in Molecular Replacement procedure, in fact the 
phase information dominates the amplitude information [23]. 
 The crystallographer interprets the electronic density and makes adjustments that 
in principle will approximate the model to the real structure. After significant 
adjustments are made, another FT is practiced resulting in reciprocal-space 
information about the structure, therefore amplitudes and phases. Mathematical 
analysis are made, further progressing phases, approximating the model’s calculated 
structure factors to the experimentally obtained. Cycles of FT and model improvement 
are made, converging the 3-D model to the structure that experimentally diffracted the 
X-Rays [23], [25], [27]. 
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1.3.6 Model analysis and validation 
 During model refinement, various parameters are used to evaluate how close it is 
to the obtained data and how much more it can be improved, such as different electron 
density maps, temperature factor, R-factors and the Ramachandran plot.  
 During model building the atoms are fitted into the electron density where there is 
enough confidence to do so. Common contour maps used are 2FO-Fcalc and FO-Fcalc. 
The 2FO-Fcalc map results in continuous density along the model, giving increased 
importance to observed structure factors over the calculated ones. The FO-Fcalc map 
is a difference map that shows negative or positive density. Positive density represents 
lack of electron density compared to what obtained data suggests, whereas negative 
density is the inverse. This map can show subtler errors that the 2FO-Fcalc [23]. 
 The temperature factor (B factor) represents the thermal vibration expected for 
each atom in the model and is expected to be lower for atoms buried inside the protein 
and higher for atoms at the proteins surface. The thermal motion of each atom is 
expected to be similar to neighbor atoms and higher for side chain than the protein’s 
backbone [23], [25], [27]. 
 Other parameter used for model analysis and validation is the R-factor - a measure 
of the proximity between the current model and the experimentally obtained data. If 
during refinement the model is converging to the real 3D structure, this factor will 
converge also to 0. There are diverse ways to calculate R-factors, the “traditional” R-
factor is given by: 
𝑅 =
∑ ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||
∑ |𝐹𝑜𝑏𝑠|
 
If the model would be perfectly equal to the structure that diffracted the X-rays R 
will be zero, whereas if Fcalc are random values from another dataset R will be 0.6 or 
higher. The Rfree is an R-factor that uses a random set of data not used in refinement 
(usually 5 %). The two factors complement each other in what the “traditional” R-factor 
tells us how well the current model predicts the obtained data and Rfree how well the 
current model is predicted by data not used to arrive to the same model [23], [25]. 
 Another way to evaluate a model is to stereochemically compare it to the amino 
acid conformations in the Ramachandran plot. These plots represent preferable and 
allowed amino acid conformations since they are physically restricted. It is allowed 
that a few outliers remain through refinement but not too many. These amino acids 
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remain outliers because they are tolerating a higher energetic cost in order to maintain 
the protein’s function. 
1.4 ISOTHERMAL TITRATION CALORIMETRY (ITC) 
Isothermal titration calorimetry (ITC) is a very powerful technique and the objective 
of using ITC was to try to obtain the kinetic constants for Cn NapAB and its interaction 
constants with various ligands, further characterizing it.  
The ITC machine contains two isotermically isolated compartments (the reference 
and the reaction cell). By altering the energy provided to the reaction cell, the machine 
maintains the temperature of both cells constantly equal. The result of the experiment, is 
the variation of energy provided to the reaction cell along time. Exothermic reactions 
occurring inside the reaction cell lead to a decrease in energy provided to the reaction cell, 
maintaining the temperature; whereas endothermic reactions lead to an increase of energy 
providence [29], [30]. 
The process of determining reaction kinetics through ITC generally requires two 
steps: the first is the acquisition of the total apparent molar enthalpy (ΔHapp) in the 
established conditions, the second is the measurement of the heat flow at different 
substrate concentrations [29]. For determining ΔHapp a single injection experiment is 
performed in which the substrate injected is totally converted into product. Because the 
substrate is totally consumed, it is assumed that the moles of product obtained are 
proportional to the moles of substrate injected; therefore, enabling to calculate the reaction 
total apparent molar enthalpy [29], [30]. After ΔHapp has been calculated, the heat flow 
(dQ/dt) for different substrate concentrations is needed. To do this there are currently two 
methods available, the multiple injection and the single injection methods [29], [30]. 
𝑣 =
𝑑[𝑃]
𝑑𝑡
=
1
𝑉. Δ𝐻𝑎𝑝𝑝
.
dQ
𝑑𝑡
 
The multiple injection method involves consistent injections of substrate into the cell 
containing the sample. Each injection is timed to permit the signal to stabilize to the new 
baseline but not for the substrate to be significantly consumed – simulating steady state 
conditions. In this method, the heat flow is calculated through the difference between the 
original baseline and the new after each injection. In the single injection, the method of 
calculating the enthalpy of the reaction is similar but requires higher substrate 
concentrations. Comparing the two methods, the single injection requires more complex 
mathematical analysis, takes less experimental time and is more resilient to base line drift 
derivate errors [29], [30]. 
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1.5 THERMAL SHIFT ASSAY (TSA) 
The thermal shift assay technique (TSA) has become very important, since it is a 
simple and fast technique able to screen various buffers and/or ligands detecting their 
influence in the protein of study. This is especially useful for macromolecular X-Ray 
Crystallography in order to discover stabilizing buffer conditions suitable for the 
crystallization assays [31]–[33]. In the TSA assays, a fluorophore that improves its 
emission efficiency when interacting with hydrophobic residues of the protein is used to 
monitor protein denaturation. As the temperature rises and the proteins start to denaturate, 
the fluorescence increases its emission and is detected in a RT-PCR machine. The melting 
temperature (Tm) – which is the temperature at which half the proteins is denatured – is 
measured for the native protein and for the protein in the presence of several ligands of 
interest and/or buffers [33]. 
 When a ligand stabilizes the protein, the Tm increases and when the ligand 
destabilizes the protein, the Tm decreases. An inhibitor that interacts exclusively with the 
folded protein active site is an example of a stabilizing ligand, whereas a ligand that 
interacts exclusively to the unfolded protein will destabilize it. Ligands that stabilize the 
protein in these assays, often also improve the macromolecular crystallization process 
[33], [34].  
The result of the technique is a melting profile for each compound tested with the 
protein and the corresponding melting temperature. The influence of each ligand is 
accessed through the comparison of melting profiles with the profile absent of any ligand 
[35].   
1.6 MICROSCALE THERMOPHORESIS (MST) 
Microscale thermophoresis (MST) is a relatively recent technique and it basically 
consists in the measurement of local loss of fluorescence after heating. The sample 
consists of at least one labeled analyte, (usually a protein labeled with a fluorophore), 
producing fluorescence and a ligand. Multiple capillaries containing the analyte and 
varying ligand concentrations are introduced into the MST machine. The machine is 
constantly measuring the emission of the fluorophore. At a certain point, it irradiates the 
center of the capillary with infrared heating. Normally the fluorescence will decay as the 
molecules will flow from the heated part of solution to the coolest, (the inverse, although 
less common, might also happen). In either case a signal profile is created depending on 
the quantity and velocity at which the molecules diffuses away (or into) the heated volume 
[36]. 
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As each capillary contains increasing concentration of ligand, if it interacts to the 
analyte it will often change the signal profile. The signal change depends on the difference 
in size, charge and hydration shell of the protein and protein-ligand complex. From the 
gradual change in signal dependent on the ligand concentration, the Kd can be obtained. 
The normal experiment consists on a capillary scan before and after the MST traces 
(Figure 1.7.a-b). These scans assess if the protein is stable enough before and throughout 
the experiment. Between these scans the MST tracing experiment is performed. This 
tracing consists measuring the fluorescence without impinging infrared light for a brief 
period of time (usually for 20 seconds). After this step, the infrared is turned on and the 
varying fluorescence is measured along time, following the fluorophore diffusion. The 
signal stabilizes after some time, at which point the velocity of diffusing molecules away 
and into the irradiated zone is the same. The infra-red is turned off again and the signal 
rapidly stabilizes to the initial signal. A comparative study is made with the non (infrared) 
irradiated fluorescence and the irradiated fluorescence [36]. 
1.7 OBJECTIVES 
 The aim of this work was to study the reaction mechanism of the periplasmic nitrate 
reductase (NapAB) from Cupriavidus necator through the use of X-Ray Crystallography 
and complementary techniques. To try to obtain the reaction mechanism intermediates 
various co-crystallization and soaking experiments were conducted using substrate, 
substrate-analogues, inhibitors and reducing agents. 
 Besides the X-Ray Crystallography studies, Isothermal Titration Calorimetry (ITC), 
Thermal Shift Assays (TSA) and Microscale Thermophoresis (MST) were also performed. 
Figure 1.7: Typical MST experimental results.  
a) superimposed capillary scans before and after the MST tracing. b) MST traces where the blue 
and red areas are the non-irradiated fluorescence and irradiated values that are being considered 
for the Kd calculations. 
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These techniques were used because they can provide complementary information on 
ligand-protein interactions, valuable for the study of the reaction mechanism. 
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2 MATERIALS AND METHODS 
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2.1 PROTEIN PURIFICATION 
The Cupriavidus necator (Cn) NapAB protein used in this work resulted from a 
homologous expression system, with the particularity that all the genetic engineering 
steps were carried out in Escherichia coli and later the resulting vector was introduced 
in an inactive strain of C. necator. An industrial growth of 300 L was carried out to obtain 
large amounts of the bacteria C. necator and after pellet resuspension the periplasm was 
isolated and frozen at -80°C in aliquots of ~1L until further usage [26]. 
In this work, the purification steps started from one of this periplasm aliquots. The 
sample was thawed in an ice-water bath, centrifuged at 13000 g for 20 min and the 
supernatant was dialyzed in 10 mM MES pH 5.5 overnight. The dialyzed solution was 
centrifuged at 13000 g for 15 min and the resulting sample was always maintained at 
4°C further on. To purify the protein the resulting supernatant was injected in a HPLC 
(High Performance Liquid Chromatography) system (Shimadzu) connected to a cation 
exchange SP Sepharose Fast Flow column (GE Healthcare) pre-equilibrated with 10 mM 
MES pH 5.5. A linear gradient of 10 mM MES pH 5.5 with 500 mM NaCl was used for 
NapAB elution. The initial flux of the column was 3 mL/min but due to technical problems 
the flux was lowered to 0.35 mL/min (overnight) and finally to 1.5 mL/min. Continuous 
absorbance at 280 nm was recorded to follow protein elution and 15 aliquots of 3 ml 
were collected.  To verify which of the collected fractions contained the NapAB protein, 
an SDS – PAGE (Sodium dodecyl sulfate – Polyacrylamide gel electrophoresis) was 
used. Samples of 15 µL were previously denatured and loaded into 13% acrylamide Tris-
Tricine gels. An electric field of 200 mA and 200 V was applied for 50 minutes and the 
NZY Color Protein Marker II (NZY Tech) was used to identify the resulting bands. 
 The fractions containing NapAB, were pooled together and concentrated using a 
Macrosep concentrator (30 kDa, Pall corporation) and later injected into a molecular 
exclusion Superdex 200 (GE Healthcare) HPLC column. The column was pre-
equilibrated with 300 mM Tris-HCl pH 7.6 and three separate runs were performed at 1 
ml/min flow collecting 1 mL aliquots. A SDS-PAGE following the previously described 
protocol was used to verify which collected samples contained the NapAB protein and 
the corresponding fractions were pooled together. 
Protein purity and concentration where assessed through SDS-PAGE and 
absorbance at 410 nm which corresponds to the two c-type heme groups (ε = 212 000 
M-1 cm-1) from NapAB. The final NapAB concentration was 16.9 mg/mL (158 µM) with a 
purity ratio (A410nm/A280nm) of 95%, also confirmed by using a plate reader). 
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Qualitative activity assays were made to ensure the purified NapAB sample was 
active. We used sulfanilamide and N-1-napthylethylenediamine dihydrochloride (NED) 
under acidic conditions to detect the presence of nitrite in various samples. This reaction 
was first described by Griess in 1879, hence the reaction mixture can be abbreviated to 
the “Griess reagent” [37], [38]. Each sample solution had a total of 500 µL and was (prior 
to the addition of the Griess reagents) 100mM Tris-HCl pH 7.6, 1 mM methyl viologen, 4 
µM NapAB and 9.2 mM sodium dithionite. After one minute, potassium nitrate was added 
to a concentration of 14 mM and the reaction was allowed to proceed for half a minute 
after which the sample was vortexed, oxidizing dithionite and stopping the reaction. A 
volume of 500 µL 35 mM sulfanilamide and 6 M HCl was added to the sample mixture 
followed by 500 µL 5 mM NED. The development of an intense pink color was then 
assessed. 
2.2 PROTEIN CRYSTALLIZATION 
2.2.1 Screening and optimization 
Crystallization assays where performed in a temperature controlled room at 20°C 
and all the necessary material was there placed for at least 30 min prior to the beginning, 
including the 24 well-plates used (Molecular Dimensions - XRL). 
Considering the previous successful C.necator NapAB crystallization studies 
[16], [26], two crystallization conditions were initially tested by the hanging drop method 
using 100 mM Bis-Tris pH 5.5 and 100 mM succinic acid pH 7.0 with 5% to 30% PEG 
3350. Different NapAB initial concentrations were also tested: 17 mg/ml, 12.75 mg/ml 
and 8.5mg/ml. The drops contained 1µL of protein solution and 1µL of precipitating 
solution (1+1) and 500 µL of crystallization solution in the reservoir. In parallel, an 
additive screen from Hampton Research (total of 48 different additives) was also tested 
by hanging drop using the crystallization condition of 0.1 M succinic acid pH 7.0, 20% 
PEG 3350 and drops composed by (1+0.25+0.75) of protein, additive and precipitant 
solution respectively. To clarify the crystallization drop composition, in all cases the 
pipetting order was: protein sample on a silanized cover slip or crystallization bridge; 
additive solution (when applied) on top of the protein drop; and precipitating solution 
followed by the sealing of the well. 
The commercial screen JCSG-plus™ from Molecular Dimensions (96 different 
crystallization conditions) was also tested using the hanging drop method and drops 
(1+1) in the search for alternative crystallization conditions. The JCSG+ screen results 
showed that 9 out of 28 initially promising conditions were worth to pursuit and were 
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reproduced using in-house made solutions. From these nine conditions, the condition 
containing 0.1 M ammonium citrate pH 5.5 with 20% PEG 3000 was selected and PEG 
concentrations of 15%, 20%, 25% and 30 % were also screened. The condition 
containing 20% PEG 3000 was originally chosen, however, co-crystallization of NapAB 
with reducing agents caused a decrease of the crystals size and an increase of the 
presence of smaller crystals. Due to this, we retested PEG 3000 for 15%, 17.5%, 20% 
and 22.5% and the condition containing 17.5% PEG 3000, 0.1M ammonium citrate pH5.5 
proved to lead to better crystals and chosen as the main crystallization condition until the 
end of this work. 
2.2.2 Co-crystallizations and soakings 
Two main crystallization methods were used in order to try to obtain the NapAB 
crystals with ligands: co-crystallization and soaking. Co-crystallization was used either 
by incubating Nap with the ligands for 30 min prior to the crystallization assay or by 
adding the ligand to the crystallization drop as an additive. Soaking experiments were 
carried out either by fishing the crystals into a new drop containing a harvesting solution 
(HB) with the ligand or by exchanging the drop by successively and gently substituting 
the mother liquid by the HB/ligand solution.  
Potassium nitrate (1 0 mM or 100 mM) and sodium nitrate (10 mM) were tested 
to verify if the salts were relevant as additives using drop volumes of  (1+0.5+0.5) and 
(1.5+0.5+1). Co-crystallization with reducing agents (DTT and TCEP at 14 mM) by 
incubation with NapAB was also tested using hanging drop (1+1; 1.5+1.5; 2+2), sitting 
drop (1+1) and the micro batch (2+2) techniques. For incubation assays the final 
concentration of the reducing agent was 14 mM and the NapAB sample concentration 
was 13.6 mg/ml. The incubation periods lasted 30 minutes for all cases. 
The incubation of Nap with reducing agents resulted in a low yield of large protein 
crystals, favoring the appearance of smaller crystals in high amounts. To improve crystal 
size of NapAB with reducing agents, we tested: (1) different Nap concentrations (158 
µM, 126 µM, 111 µM and 79 µM); (2) different drop volumes (1+1; 1.5+1.5 and 2+2); (3) 
decreased crystallization temperature at 4 0C; (4) urea and potassium nitrate as 
additives, through the hanging drop, sitting drop and micro batch techniques. Urea was 
tested because it was present in the additive screen (with succinic acid pH 7.0 and 20% 
PEG 3350) and showed to decrease protein nucleation in the drops. Optimal conditions 
were found for the reducing agent TCEP and were later used to co-crystallize NapAB 
with other reducing agents: sodium dithionite and methyl viologen. DTT was no longer 
used for incubation due lack of suitable crystallization results. 
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 For the soaking experiments, we used a harvesting buffer solution (HB) 
containing 25% PEG 3000, 0.1 ammonium citrate pH 5.5 and the ligands in a similar 
concentration as in the co-crystallization assays. The precipitant concentration was 
higher than in the crystallization assays in order to prevent the crystals to dissolve. The 
soaking experiments were made either by transferring single crystals to new drops 
containing the HB or by gently exchanging the mother-drop solution in which the crystals 
grew by the HB solution. The last method was performed by repeatedly adding between 
Co-crystallization as additives or soakings 
Co-crystallization by incubation 
(Reducing agents) 
Potassium/Sodium 
Nitrate (K/NaNO3) 
 
Di-Potassium Carbonate 
(K2CO3) 
 
TCEP - Tris(2-carboxyethyl)phosphine 
hydrochloride (C9H15O6P)  
 
Potassium 
Thiocyanate (KSCN) 
 
Potassium Cyanide 
(KCN) 
 
Urea 
(CH4N2O) 
 
Sodium Nitrite 
(NaNO2) 
 
Dit. – Sodium Dithionite 
(Na2S2O4) 
 
Sodium Perchlorate 
(NaClO4) 
 
Sodium Sulfite (Na2SO3) 
 
DTT - Dithiothreitol 
(C4H10O2S2) 
 
Lithium Chloride (LiCl) 
Sodium Azide 
(NaN3) 
MV - Methyl Viologen 
(C12H14Cl2N2) 
Table 2-1: Summary of ligands used in the co-crystallization assays: reducing 
agents, substrates, substrate- analogues and inhibitors. 
In parentheses the chemical formulas, underlined the acronyms and below the 2D structure of 
the compounds. Potassium cyanide, potassium thiocyanate, and sodium azide, perchlorate and 
carbonate where expected to act as NapAB inhibitors/substrate inhibitors. 
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1 to 2 µL of the harvesting solution to the drop and then pipetting out the same volume 
from the drop no less than eight times. For soaking experiments longer than 10 minutes, 
a volume of 100 to 200µL from the same HB solution was added to the well and it was 
closed with the cover slip containing the crystals drop to prevent it from drying. 
 Crystallization trials were also performed inside an anaerobic chamber, in the 
absence of oxygen (O2>70ppm). All the required material was deoxygenated with 
gaseous nitrogen for 15 minutes and introduced into the chamber after 3 vacuum cycles. 
After 30 minutes inside the chamber, the crystallization assays were started using the 
previously described procedure. Crystals grown in the anaerobic chamber were removed 
from the chamber and rapidly transferred to the harvesting solutions in an aerobic 
environment. The various compounds tested by co-crystallization and/or soaking are 
shown in Table 2-1. 
Crystals were observed with a SteREO Discovery.V12 (Zeiss) microscope and those 
that seemed suitable for diffraction experiments (see below) were transferred to a cryo-
protector solution containing 30% glycerol, 25% PEG 3000 and 0.1M ammonium citrate 
pH 5.5. We evaluated crystals morphology and size and chosen the ones with marked 
edges (over round-edged crystals) and crystals with suitable size for manipulation (> 0.1 
mm) while avoiding multiple crystals. We were often able to choose crystals equal to or 
bigger than 0.1 mm in the smallest dimension. The crystals were rapidly incubated in the 
cryo-protecting solution and flash-frozen in liquid nitrogen in order to prevent ice crystals 
to form.  
2.3 DATA COLLECTION, PROCESSING AND STRUCTURE DETERMINATION 
 The NapAB crystals were tested in-house using a Bruker D8 Venture dual source 
X-ray generator, a Photon 100 CMOS detector and an Oxford cryo-system. To achieve 
higher resolution data the crystals were also tested at several synchrotron facilities. 
Diffraction data were collected at the European Synchrotron Radiation Facility (ESRF – 
Grenoble, France) beamlines ID 29, 30B and at the Diamond Light Source (DLS – 
Harwell, United Kingdom) beamline I24.  
 For data reduction and indexing the programs iMOSFLM and XDS were used 
[39], [40]. For data scaling and merging the program AIMLESS from CCP4i2 suite was 
used [41], [42]. We evaluated the output observing the CC1/2, I/σI and completeness 
values variations throughout resolution shells and determined for each dataset what 
resolution shells would be cut-off.  
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 To solve the phase problem, molecular replacement was carried with PHASER 
[43]  using a NapAB Cn model (PDB code: 3ML1) from which water molecules and other 
ligands were removed.  
2.3.1 Model Building and Refinement 
Refinement cycles were done with the REFMAC5 program [44]. For each data set, 
visual inspection and manual fitting were performed using the program COOT preceded 
by REFMAC5 cycles [44]. During refinement cycles, evaluation of the current model was 
assessed by observing the decrease and convergence of Rfactor and Rfree, the number of 
outliers in the Ramachandran plots as well as visual inspections of the manually fitted 
atoms. 
For adding water molecules into the refining models, the automatic water 
insertion command from COOT [45] was used followed by visual inspection of the 
electron density, temperature factor and distance to surrounding atoms. 
For ligand insertion into the refining models, the ligand structure and restraints 
were obtained using the program COOT and the HIC-Up website. [45], [46].  
2.4 THERMAL SHIFT ASSAYS (TSA) 
We performed TSA using a real-time PCR system (StepOnePlusTM- Applied 
Biosystems) and the Protein Thermal Shift Dye KitTM [47]. Each reaction well 
(MicroAmp® Fast 96-well Reaction Plate 0.1 mL) contained: ligand solution varying in 
concentration, 1.7 mg/mL (15.8 µM) NapAB and of pre-diluted Dye solution as advised 
in the kit’s protocol [47]. Temperature was initially stabilized to 25 °C for 2 minutes 
followed by a gradual increase to 99 °C for 50 minutes and another 2 minutes 
stabilization. 
 For each assay, the NapAB sample used was always fresh. Several ligands and 
reducing agents were tested and are summarized in Table 2-2. In the cases where 
NapAB was incubated with a reducing agent, its concentration was 10 % lower than in 
the non-incubation assays.  
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2.5 ISOTHERMAL TITRATION CALORIMETRY (ITC) 
Isothermal Titration Calorimetry was performed using a TA Instruments Nano ITC 
machine. Samples were placed in vacuum (25 °C) for 8 minutes before each assay to 
avoid any solid material in the samples. Reaction cell volume was 1 mL and stirring 
speed was 250 rpm. 
We tested NapAB at 0.2 µM, 17.5 µM TCEP and titrated a 5 mM potassium nitrate 
solution. Six potassium nitrate injections of 15 µL were made into the reaction cell, 
varying the potassium nitrate concentration in the reaction cell between 74 µM and 412 
µM.  
2.6 MICROSCALE THERMOPHORESIS (MST) 
We performed MST with a Monolith NT 1.115 (NanoTemper Technologies) and the 
Monolith NT™ Protein Labeling Kit RED - NHS was used to mark NapAB solvent 
accessible lysine residues. The buffer was exchanged to one provided by the kit 
(composition not known) in order to avoid the Tris buffer competition with the labeling 
reaction. The final concentration of the labelled NapAB sample was 4.4 µM. A series of 
 
Nap incubation Ligand Ligand concentration (mM) 
- KNO3 2.5; 5; 10 
- NaNO3 2.5; 5; 10 
- KClO4- 5; 10; 20 
- TCEP 2; 5; 10; 15; 35 
TCEP 14mM KNO3 5; 10; 20 
- Dithionite 5; 14; 20; 30; 40 
Dithionite 14mM KNO3 2.5; 5; 10 
Dithionite 20mM KNO3 2.5; 5; 10; 20 
Dithionite 30mM - - 
Dithionite 30mM KNO3 2.5; 5; 10 
- NaNO2 2.5; 5; 10 
Dithionite 30mM NaNO2 2.5; 5; 10 
- DTT 5; 15; 20 
DTT - - 
Table 2-2: Summary of different conditions tested for NapAB Cn in TSA.  
The first column indicates when NapAB was incubated for 20-30 minutes prior to the beginning 
of the assay. The second and third columns indicate what ligands and concentrations were 
tested. For the cases where no ligand was tested, the corresponding ligand volume (10µL) was 
buffer (Tris-HCl 300mM pH 7.6). 
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preliminary tests were made to establish the optimal assay conditions. For an adequate 
signal, NapAB was diluted to 0.044 µM and 0,05 % Tween 20 (Polyoxyethylenesorbitan 
monolaurate) was added to the protein solution. Labelled NapAB samples were 
centrifuged at 9000 g for 10 minutes (4 °C) immediately before each assay and loaded 
into MST Premium Coated Capillaries (NanoTemper Technologies). 
Binding affinity assays consisted of 16 different sodium and potassium nitrate 
concentrations. Two-fold serial dilutions produced the 16 different solutions for each 
assay and are presented in Table 2-3.  
Capillary Nº 
NaNO3 
 (mM) 
KNO3 
 (mM) 
NaNO3 
and KNO3 
(mM) 
NaNO3  
(mM) 
NaNO3  
(mM) 
1  300 500 1500 3000 4500 
2  150 250 750 1500 2250 
15  0.02 0.03 0.09 0.18 0.27 
16  0.01 0.02 0.05 0.09 0.14 
 
 
Table 2-3 - MST Binding Affinity Assays. 
This table shows the ligand concentrations for capillaries 1, 2, 15 and 16 for each assay. 
Nitrate’s counter ions potassium and sodium are varied for reasons explained in chapter 3.6. 
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3 RESULTS AND DISCUSSION 
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3.1 PROTEIN PURIFICATION AND ACTIVITY ASSAYS 
The NapAB protein was purified from an aliquot of previously isolated Cupriavidus 
necator (Cn) periplasm kept at -80 °C. Two chromatographic purification steps were 
performed using a cation exchange SP Sepharose column followed by a size exclusion 
Superdex 200 column (Figure 3.1). 
Due to technical difficulties during the SP Sepharose HPLC, the corresponding 
chromatogram was saturated from the minute 54 onwards (data not shown). The collected 
fractions suspected to contain the NapAB elution were loaded on an SDS – PAGE gel for 
qualitative filtration. The fractions 39 – 53 contained the NapAB sample, and were pooled 
together and concentrated using a Macrosep (Pall corporation) of 30 kDa (Figure 3.1.b).  
Figure 3.1: Characterization of the NapAB purification.   
a) Chromatogram of the molecular exclusion Superdex 200 column (absorbance 280 nm). b-d) 
SDS-polyacrylamide gels of the purified NapAB. Results from the SP Sepharose (b) and from one 
of the three Superdex 200 chromatograms (c). The final NapAB sample (d) concentrated to 17 
mg/mL. In all cases the NZY Color Protein Marker II was used and the 100, 63, 35 and 17 kDa 
marks are indicated. A white bar indicates pooled fractions for the main NapAB sample. e) Spectrum 
of native NapAB from 260-680 nm. The Soret band is visible at 409 nm. 
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Due to the large amount of NapAB obtained three separated runs (in similar 
conditions) were performed using the Superdex 200 column (Figure 3.1.a) in all cases 
followed by an SDS – PAGE for evaluation of the NapAB containing fractions. The resulting 
fractions 55-63 (Figure 3.1.c) were concentrated to a final concentration of 158 µM and the 
final buffer composition was 300 mM Tris-HCl pH 7.6. An SDS – PAGE of the final NapAB 
sample is shown in Figure 3.1.d. The NapAB concentration was calculated using the Soret 
band absorption at 409 nm (ε=212000 M-1 cm-1) in a spectrophotometer and in a plate 
reader. Aliquots of 250 µL, 100 µL and 50 µL were stored at -80 ºC for further usage.  
To test for NapAB activity, a qualitative assay was performed using methyl viologen 
as the electron donor and sodium dithionite as reducing agent. The development of a very 
intense pink color after adding sulfanilamide and N-1-napthylethylenediamine 
dihydrochloride (NED) under acidic conditions confirmed the detection of the enzymatic 
reaction product nitrite in solution. This showed that the NapAB protein was fully active and 
able to be used in the further biochemical characterization assays. 
The UV-Vis NapAB spectrum (Figure 3.1.e) contains the protein absorbance peak at 
280 nm and the Soret band at 410 nm corresponding to the two heme groups, but lacks the 
iron-sulfur cluster characteristic absorbance between 350-500 nm due to the heme 
absorbance bands [16].  
3.2 PROTEIN CRYSTALLIZATION 
3.2.1 Screening and Optimization 
3.2.1.1 Bis-Tris and Succinic Acid 
We tested the previous successful C. necator NapAB crystallization conditions with 
PEG 3350 [16], [26] using 100 mM Bis-Tris pH 5.5 and 100 mM succinic acid pH 7.0, at 
20 C and NapAB at 158 µM. The PEG 3350 concentration was screened between 5 %, 
10 % and 15 % (using Bis-Tris) and 10 %, 15 %, 20 % (using succinic acid). The condition 
with Bis-Tris did not result in any crystalline material while the succinic acid conditions 
contained needles, “urchins” and microcrystals when using 20% PEG. Following these 
results, we tested 100 mM succinic acid pH 7.0 with increased PEG 3350 concentration 
(25% and 30%) and lower NapAB concentration (80 µM.) In all cases drops were (1+1) 
and the reservoir contained 500 µL. When using 30 % PEG 3350 and NapAB at 158 µM 
the results showed protein amorphous precipitates while when using 25% PEG 3350 
resulted in higher numbers of microcrystals (Figure 3.2.a). The NapAB dilution tests (80 
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µM) showed a mixture of amorphous precipitates, needles and urchins for 25% PEG; 
needles and 2D crystals for 20 % PEG; and no precipitation for 15 % PEG. 
We also tested the additive screen from Hampton research using 100 mM succinic 
acid pH 7.0, 20 % PEG 3350 and drops (1+0.25+0.75) corresponding to protein, additive 
and precipitant respectively. From this screen only 2 conditions resulted in significant 
crystalline material when using 0.1 M urea (Figure 3.2.b) and 0.1 M manganese chloride, 
to a final concentration of 12.5 mM in the drop. Urea seemed to act as a nucleation 
inhibitor, resulting in a well-defined crystal and a few needles originating from it. The 
manganese additive resulted in “urchins” with few crystals in the center.  
3.2.1.2 The JCSG+ screen 
In order to search for novel crystallization conditions, the JCSG+ screen (96 conditions 
from Molecular Dimensions) was used manually and as a result a total of 28 different 
conditions provided promising results – including needles, “urchins” , 2D crystals and 
defective 3D crystals (Figure 3.2.c-f). The best results were from conditions containing 
0.2 M ammonium citrate and 20% PEG 3350; and 0.1 M sodium citrate pH 5.5 with 20% 
PEG 3000 (Figure 3.2.f). Since so many conditions provided crystalline material (28 hits), 
the results were also interpreted from a statistical point of view from which the following 
was observed: 15 conditions (54%) contained 20% of PEG of any molecular weight; 14 
Figure 3.2: Results from the crystallization screens. 
(a) Crystallographic results from the succinic acid condition (100 mM succinic acid pH 7.0, 25% 
PEG 3350; (b) from the additive screen, 12.5 mM urea as additive (100 mM succinic acid pH 7.0, 
25% PEG 3350); (c-f) from the JCSG+ 200 mM Potassium formate, 20% PEG 3350 (d) 100 mM 
BICINE pH 9, 20% PEG 6000 (e) 200 mM Sodium thiocyanate, 20% PEG 3350 and (f) 100 mM 
Sodium citrate, 20% PEG 3000. 
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conditions (50%) contained any concentration of PEG 3350; 10 conditions (36%) 
contained exactly 20% PEG 3350; 6 conditions (21%) contained citrate buffers. 
These results led us to conclude that the major factors contributing to the high number 
of crystalline hits in the JCSG+ screen was the presence of PEG 3000/3350 as the 
precipitating agent and its concentration ~ 20%. The number of hits containing citrate 
buffers were also considered significant. Therefore, we set on to test different PEG 
concentrations (15%, 20%, 25% and 30%), molecular weights (3000 and 3350) as well as 
citrate buffers (ammonium citrate and sodium citrate), in all cases using a pH of 5.5. The 
results corroborated that the most defining factor was the PEG concentration. Between 
PEG 3000 and 3350 no significant difference was observed and ammonium citrate 
produced slightly better results than sodium citrate. Using 30% and 25% PEG resulted in 
amorphous precipitate mixed with microcrystals; 20% PEG resulted in acceptable 
numbers of well-defined 3D crystals mixed with microcrystals; 15% PEG provided few or 
no crystalline material. We selected 100 mM ammonium citrate pH 5.5 and 20% PEG 3000 
as the main crystallization condition in future experiments, using drops of (1+1), with 500 
µL of the crystallization condition in the reservoir at 20 C and initial NapAB concentration 
of 158 µM.  
These results can be interpreted in a crystallization phase diagram, where PEG 
concentrations higher than 17.5% up to 25% gradually remain in the nucleation zone, 
stimulating the number of nucleus/crystals and lowering the average crystal size. Higher 
than 25% PEG concentrations reach the fast precipitation zone producing amorphous 
precipitates and lower PEG concentrations (<17.5%) gradually stay in the nucleation zone, 
producing a lower number of crystal nucleus, if any at all. 
3.2.2 Co-crystallization with reducing agents  
In an attempt to obtain the reduced form of Nap, the protein was incubated with 
reducing agents prior to crystallization. The first reducing agents to be tested were DTT 
and TCEP at 14 mM. The first preliminary results showed that no crystalline material was 
observed when using DTT. By contrary, when using TCEP an increase in nucleation 
resulting in higher amounts of smaller crystals was observed. 
Various assays were made aiming to obtain crystals with DTT and optimize the 
crystals with TCEP. Potassium nitrate and urea were tested as additives for TCEP 
incubated NapAB co-crystallization assays. In contrast to urea, potassium nitrate seamed 
to improve the crystal size. Potassium nitrate was used because it was previously 
observed to significantly improve crystal size and decrease nucleation in other co-
crystallization studies [15]. Urea was tested because it showed decreased nucleation 
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when applied through the additive screen from Hampton Research as previously 
mentioned. However, this screen was only tested with the succinic acid crystallization 
condition and not with ammonium citrate.  
Both vapor diffusion techniques (hanging and sitting drop) were tested in the search 
for the best crystallization condition, and we observed that using hanging drop provided 
more single crystals than sitting drop. Using a drop volume of (1.5+1.5) produced higher 
amount of suitable crystals than using (1+1) but was in average equal to (2+2). We chose 
(1.5+1.5) as the default drop volume to use for TCEP co-crystallizations since it produced 
similar results with expend of less amount of protein. We tested three different NapAB 
concentrations (126 µM, 111 µM and 79 µM – diluted from the initial 158 uM NapAB 
concentration) using 14 mM TCEP solutions or 300 mM Tris-HCl pH 7.6 as control. The 
results showed that a NapAB concentration of 126 µM was ideal for the TCEP co-
crystallizations. By comparison with the controls we also noticed that NapAB concentration 
of 126 µM was best even for non-TCEP co-crystallization assays (we had previously tested 
NapAB concentrations of 158 µM and 80 µM). Crystallization at 4 ºC was also tested and 
Figure 3.3: Results from crystallization optimization and co-crystallization with 
DTT, TCEP and potassium nitrate.  
In all cases the buffer was 100 mM ammonium citrate pH 5.5. a) microbatch using mineral oil and 
20% PEG 3000 and 158 µM Nap; b) 20% PEG 3000 and 158 µM Nap; c) 17.5% PEG 3000 and 
158 µM Nap; d) 17.5% PEG 3000 and 126 µM Nap e) 17.5% PEG 3000 and 126 µM Nap co-
crystallized with 100 mM potassium nitrate and 14 mM TCEP; f) 17.5% PEG 3000 and 126 µM Nap 
co-crystallized with 100 mM potassium nitrate in the anaerobic chamber. 
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resulted in a drastic increase of microcrystals for both native and TCEP co-crystallization 
assays.  
The microbatch technique was also tested using mineral oil and (2+2) drop volume 
to try to maintain the reducing conditions when using TCEP and DTT. NapAB 
crystallization as well as co-crystallization assays with TCEP, DTT, potassium nitrate, 
TCEP with potassium nitrate and DTT with potassium nitrate were performed. Microbatch 
resulted in fewer and smaller crystals when comparing to hanging drop and was the only 
case were DTT co-crystallizations resulted in crystalline material, producing very small and 
round-edged crystals. (Figure 3.3.a). 
We had previously tested PEG 3000 concentrations of 15%, 20%, 25% and 30% for 
native NapAB and opted to use 20% PEG as the default crystallization condition. Because 
TCEP induced nucleation, we retested the PEG concentrations this time for 15%, 17.5%, 
20% and 22.5%. We noticed 17.5% PEG 3000 provided the best crystals for both TCEP 
incubated and native Nap, significantly increasing the crystal size. 
By optimizing the co-crystallization of NapAB with TCEP, we fine-tuned the PEG 
concentration from 20% to 17.5% (Figure 3.3.b-d). The final optimized crystallization 
condition – 100 mM ammonium citrate pH 5.5, 17.5% PEG 3000 and 3 µL total volume 
drops – was used as the default until the end of this work. Co-crystallization of NapAB with 
TCEP slightly reduced the number of multiple crystals. Additionally, when potassium 
nitrate was used as additive in (1.5+0.5+1) drops, an increase in crystal size accompanied 
by a decrease of multiple crystals and numbers of crystals was observed (Figure 3.3.e). 
NapAB crystals grew to its maximum size in 7 days, with the first crystalline material 
appearing after the first 24 hours. The crystals grew to about 80% of their maximum size 
in 3 days and common crystal dimensions were 0.3 x 0.2 x 0.2 mm. This crystallization 
condition was also used for co-crystallization assays using sodium dithionite and methyl 
viologen and as a result both reducing agents showed a slight decrease in the number 
and size of crystals in the drop. 
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3.2.3 Other co-crystallization and soakings 
A table with the effects that various ligands have on NapAB co-crystallizations 
assays is shown below (Table 3-1). Co-crystallizing with either sodium or potassium 
nitrate, in an attempt to obtain the crystals structure of the NapAB-substrate complex, 
significantly improved crystal size and decreased nucleation. This effect was observed 
even when using simultaneously the reducing agents TCEP, sodium dithionite and methyl 
viologen. We did not observe significant differences between sodium and potassium 
Ligand 
Verified effect in co-
crystallizations 
Structure 
obtained 
Other comments 
NaNO3- Increase in crystal size;  
Nucleation inhibition 
Yes - 
KNO3- 
Dithionite Induced Nucleation  Yes - 
KNO2- 
No significant effect 
observed 
Yes - 
Methyl 
viologen 
Induced Nucleation Yes 
Crystal breach openings during 
soakings 
TCEP 
Induced Nucleation; 
Crystal multiplicity 
reduction 
Yes - 
Urea Induced Nucleation Yes 
Nucleation inhibition verified only 
for the succinic acid crystallization 
condition 
MnCl2 
“Urchins” and crystals in 
the center 
Yes - 
K2CO32- 
Needles / micro-crystals 
(*) 
Yes - 
KCN - No crystals 
Only in 
soakings 
- 
NaN3- No crystals 
Only in 
soakings 
- 
NaSCN- Defective crystals 
Only in 
soakings 
- 
ClO4- No crystals No - 
DTT No crystals (**) No - 
LiCl- Needles / micro-crystals No - 
Na2SO32- Defective crystals No - 
Table 3-1- Summary of the various NapAB ligands and effects in the co-
crystallization experiments. 
In red are compounds that were used as reducing agents, in green the substrate and product 
of Nap and in blue other compounds like Nap inhibitors, substrate homologous or ligands from 
the additive screen used in this work. MV stands for methyl viologen and Dith for dithionite. (*) 
Crystals suitable for diffraction were only obtained when co-crystallizing with methyl viologen. 
(**) When using the microbatch technique, crystals were observed with a low degree of 
reproducibility. 
 
Figure 3.5 – Comparison of the different unit cells obtained.Table 3-2- Summary 
of the various NapAB ligands and effects in the co-crystallization experiments. 
In red are compounds that were used as reducing agents, in green the substrate and product 
of Nap and in blue other compounds like Nap inhibitors, substrate homologous or ligands from 
the additive screen used in this work. MV stands for methyl viologen and Dith for dithionite. (*) 
Crystals suitable for diffraction were only obtained when co-crystallizing with methyl viologen. 
(**) When using the microbatch technique, crystals were observed with a low degree of 
reproducibility. 
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nitrate, but noticed a slight increase in crystal size when comparing drops of (1.5+0.5+1) 
to (1+0.5+0.5).  
Various NapAB inhibitors were used in co-crystallization and soaking assays with 
the objective of blocking or slowing catalysis, aiming to obtain the crystal structure of a 
NapAB reaction mechanism intermediary. We tested the NapAB inhibitor potassium 
cyanide [48] by co-crystallization and soaking. No crystals were obtained in the co-
crystallization assays and NapAB crystals showed signs of degradation during the soaking 
experiments with potassium cyanide. We also tested sodium thiocyanate for the same 
purposes, although no crystals were obtained during co-crystallization assays, the soaking 
experiments did not result in the degradation signs that the cyanide soakings did.  
We also attempted to co-crystalize NapAB with potassium carbonate, potassium 
perchlorate and potassium sulfite. Co-crystallization assays with potassium carbonate did 
not result in crystals suitable for diffraction but soaking NapAB crystals with potassium 
carbonate did not perturb the crystals. Also, crystals were obtained when co-crystallizing 
NapAB with methyl viologen and potassium carbonate. Co-crystallization assays with 
potassium perchlorate and potassium sulfite did not result in suitable crystals for 
diffraction.  
Various crystallization assays were made in the anaerobic chamber. However, 
besides a lower degree of reproducibility, we did not observe any significantly difference 
when comparing crystallization assays in or out of the chamber (Figure 3.3.f). 
3.3 DATA DIFFRACTION AND MODEL INTERPRETATION 
We tested the NapAB crystals in-house using a Bruker D8 Venture dual source X-
ray generator, a Photon 100 CMOS detector, and an Oxford cryo-system and the crystals 
diffracted to 3.3 Å maximum resolution. Because the objective of this work was to study 
the NapAB reaction intermediates, higher resolution structures were needed. To achieve 
higher resolutions, we sent the crystals to third generation X-Ray sources and diffraction 
data were collected at the European Synchrotron Radiation Facility (ESRF – Grenoble, 
France) beamlines ID 29, 30B, at the Diamond Light Source (DLS – Harwell, United 
Kingdom) beamline I24 and at the Deutsches Elektronen-Synchrotron (DESY – Hamburg, 
Germany) beamline P13 (PETRA III). 
The majority of the crystals (summary in table 5 - 6) belong to space group C2 with 
unit cell parameters a = 135 Å, b = 71 Å, c = 114 Å and β = 110°. The only exception was 
a NapAB crystal consecutively soaked in several different solutions (first methyl viologen, 
followed by sodium dithionite, potassium nitrate and sodium azide) with the following unit 
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cell parameters a = 141.6 Å, b = 83.2 Å, c = 97.3 Å and β = 101.3°. Interestingly, these 
unit cell parameters are similar to the parameters obtained by the previous NapAB studies 
(Coelho et al. 2007) using other crystallization conditions: a = 142.2 Å, b = 82.4 Å, c = 96.8 
Å and β = 100.7°. Another NapAB study using ionic liquids resulted in different unit cell 
parameters from any structure obtained in this work, but also presented a space group C2 
(a = 119.4 Å, b = 71.4 Å, c = 128.4 Å, b = 121.01°) [49]. All NapAB crystals sent to 
synchrotron beamlines are presented in tables 3.2 and 3.3. 
The NapAB crystals soaked first in methyl viologen followed by dithionite and 
potassium nitrate did not diffract whereas, similar crystals that received a final soaking in 
sodium azide did diffract up to 1.73 Å. These soakings had the intention of mimicking the 
activity assays were dithionite, methyl viologen and nitrate are used. It is possible that 
dithionite and methyl viologen pre-activate NapAB enabling catalysis to occur. When such 
crystals are soaked in the inhibitor sodium azide, the catalysis is prevented and the crystals 
may return to the original state and diffraction becomes possible again.  
Figure 3.4: Comparison of the different unit cells obtained. 
To the left a unit cell of a NapAB crystal obtained with 0.1 M ammonium citrate pH 5.5, 17.5% PEG 
3000; the unit cell constants are also shown in black below. To the right, the unit cell of a NapAB 
crystal soaked in methyl viologen, followed by sodium dithionite, potassium nitrate and sodium 
azide; the unit cell constants are also shown in orange below. In the middle bellow is the comparison 
of the two unit cell constants. 
 
Table 3-3 – Summ ry of the results from the Nap crystals obtained in aerobic 
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Table 3-2 – Summary of the results from the Nap crystals obtained in aerobic 
conditions and tested in the various synchrotron beamlines. 
In red are compounds that were used as reducing agents, green the substrate and product of Nap 
and blue other compounds like Nap inhibitors or substrate analogs. MV stands for methyl viologen 
and Dith. for sodium dithionite. (*) Nap crystals whose diffraction data was collected without enough 
completeness to solve the structure. (**) Nap crystals that were sent to the synchrotron beamline 
but were not measured. 
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The NapAB crystals obtained from co-crystallization with methyl viologen often 
suffered damage during the soaking experiments. The crystals start to crack immediately 
after the soaking, but this could be regenerated after a few hours in the soaking conditions. 
Even crystals that were fast cooled with this type of damage, had recovered its initial 
appearance when observed again at the synchrotron beamlines. We also noticed 
significant differences between soaking the NapAB crystals with methyl viologen or co-
crystallizing NapAB with methyl viologen. NapAB crystals soaked in methyl viologen and 
then soaked in sodium dithionite with nitrate did not diffract, whereas the NapAB co-
crystallized with methyl viologen which were then soaked in sodium dithionite and nitrate 
did diffract up to 2.3 Å. If however no final nitrate soak was done, the same crystals did 
not diffract either. Additionally, dithionite co-crystallized NapAB crystals soaked in methyl 
viologen also diffracted up to 2.1 Å. Crystals that suffered damage during the soaking 
experiments with methyl viologen and recovered corroborate this hypothesis and suggest 
the structural change would be reversible. The fact that soaking or co-crystallizing NapAB 
with methyl viologen has different results also suggests that methyl viologen induces some 
kind of structural change in the crystal. However, we did not find significant structural 
changes when comparing the model with the one from the native crystal structure. 
The previous C. necator NapAB studies showed a crystal structure where the 
Cys152, which coordinates the Mo atom, seems to adopt an alternate type of conformation 
corresponding to a partial reduced form of the enzyme [16]. This model corroborated the 
theoretical calculations made for elucidation of the reaction mechanism ([17], [18]). In our 
Co-crystallization 
Soaking Best res. (Å) Nº of tested crystals and soaking time Beamlines 
Incubation Additive 
TCEP KNO3- 
- 1.9 2 
DLS I24 
KNO3- 2 2 
TCEP No diffraction 2 
TCEP  KCN - 1.9 3 
Dithionite 
- - 2 5 
- KNO3- 1.9 
2 – 5min 
2 – 15min 
2 – 30min 
KNO3- 
- 2.0 2 
KNO3- 2.0 2 
KNO2- 2.2 2 
 
Table 3-3 – Summary of the results from the NapAB crystals obtained in anaerobic 
conditions. 
In red are compounds that were used as reducing agents, green the substrate and product of 
NapAB and blue other compounds like NapAB inhibitors or substrate homologous.  
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studies, various co-crystallizations experiments using sodium dithionite and TCEP were 
made in order to obtain the reduced form of the enzyme. We found similar electron density 
in the Mo coordinating cysteine (Figure 3.5), suggesting an alternate conformation and 
further corroborating the previous studies.  
Additionally, crystal structures in which nitrate was used in combination with one of 
the reducing agents (sodium dithionite or TCEP), a nitrite molecule was found in the cavity 
that leads to the active site of NapAB 12 Å from the Mo atom (Figure 3.6). This suggests 
that the crystallized NapAB is fully active, and that both sodium dithionite and TCEP are 
capable of pre-activating it. The NapAB spectrums with dithionite (Figure 3.7) 
corroborates this by showing a Soret band shift from 410 to 420 nm and the appearance 
of two bands at 550 nm and 522 nm that are characteristic of c-type heme reduction. 
However, the ITC results (explained below) seems to suggest that TCEP is not able to 
activate Nap. It is possible that both reducing agents can to some extent activate NapAB 
but at a drastically lower rate and/or efficiency, enough for the nitrite molecules to be 
detected in crystal structures (after several days since the crystals’ growth until reaching 
synchrotron beamlines), but insufficient for the activity assays.  
Figure 3.5 - Crystal structure of partially reduced Nap and nitrite in nitrate co-
crystallized Nap. 
This crystal structure was obtained by co-crystallizing Nap with TCEP and potassium nitrate in 
aerobic conditions. The statistics on data collection and refinement are presented in Table 3-4. 
Zoom in of cysteine 152 is shown. a) cysteine 152 and the occupancy of the alternate position. b) 
refinement of the same data as a) without the cysteine 152 alternate conformation. The electron 
density is contoured at 1. 
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3.3.1 Oxidized cysteines 
In the previous studies of NapAB from C. necator  cysteine 784 was found to be 
oxidized to sulfonic acid [16]. Also, cysteine 388 showed extra positive electron density 
Figure 3.6: Crystal structure of nitrite in nitrate co-crystallized Nap. 
This crystal structure was obtained by co-crystallizing Nap with TCEP and potassium nitrate in 
anaerobic conditions. The statistics on data collection and refinement are presented in Table 3-4. 
Zoom in of the nitrite molecule is shown.  a) nitrite molecule and distances to the closer surrounding 
atoms. The average B factors of the nitrite molecule is 33, surrounding waters 26 and amino acids 
21 b) refinement of the same data as a) without a nitrite molecule. 
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but to a lesser extent than cysteine 784 and was left unmodified. As indicated by Coelho 
et al. 2011, although cysteine 784 is not conserved, cysteine 388 is highly conserved 
among the periplasmic nitrate reductases. Both residues are solvent accessible, the 
cysteine 784 is located at the entrance to the channel that leads to the active site whereas 
cysteine 388 is located in the same channel, but closer to the active site – only 10 Å from 
the Mo atom (Figure 3.8). Because the oxidation of amino acids might have functional 
roles, namely as redox-sensitive regulatory switches [16], [50]–[52], we verified all the 
cysteine and methionine residues in the structures (the NapAB from C. necator has 14 
Cys and 25 Met residues in total). No other Cys/Met residue showed this type of oxidation. 
This might also be related with the radiation damage from the X-rays, as ionizing radiation 
is known to lead to the oxidation of cysteines and methionines. It is known that the X-rays 
can lead to hydrogen peroxide formation, which reacts with cysteines resulting in sulfenic 
acid (CySOH). After the formation of sulfenic acid, further oxidation can occur to sulfinic 
acid (CySO2H) and then sulfonic acid (CySO3H) [53].  
In our studies, we confirmed that NapAB co-crystallization with sodium dithionite 
resulted in the cysteine 784 being oxidized to sulfonic acid (Figure 3.8). We also observed 
the same effects in the TCEP co-crystallizations, however in the co-crystallizations using 
methyl viologen we found a more pronounced extra positive electron density for cysteine 
388. We refined cysteine 784 as sulfonic acid and cysteine 388 as sulfinic acid (Figure 
3.8). We also found that in structures obtained from crystals growth in the anaerobic 
chamber, both cysteine residues 784 and 388 lacked any extra positive electron density 
Figure 3.7 : Spectrum of NapAB with sodium dithionite. 
The spectrum of NapAB is shown in orange, NapAB with 14 mM sodium dithionite in blue and 14 
mM sodium dithionite in dashed black. A Soret band shift from 410 to 420 nm and the appearance 
of two bands at 550 nm and 522 nm are visible for the NapAB spectrum with sodium dithionite. 
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that might suggest their oxidation. It is possible that in an anaerobic environment, the 
reaction that results in hydrogen peroxide formation (Na2S2O4+O2+H2O → 
2NaHSO3+H2O2) is non-existent and therefore, oxidation of the cysteine 388 and 784 is 
Figure 3.8 : Crystal structure of Nap zooming the oxidized cysteines 388 and 784 in 
the subunit NapA. 
This crystal structure was obtained by co-crystallizing Nap with methyl viologen and potassium 
nitrate. The statistics on data collection and refinement are presented in Table 3-4. Zoom in of 
cysteines 388 and 784 are shown and the temperature factors for each atom of the main chain, 
including alpha carbons. a) cysteine 784. b) cysteine 388. c) cysteine 784 refined as sulfonic acid. 
d) cysteine 388 refined as sulfinic acid. 
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not observed. The electron density of cysteine 152 in structures obtained from anaerobic 
growth crystals that were co-crystallized or soaked with TCEP or sodium dithionite was 
however still observed, corroborating an alternate conformation for TCEP or dithionite co-
crystallizations. We also solved a few structures by cutting-off diffraction patterns collected 
Table 3-4: Statistics on data collection and structure refinement. 
Values in parenthesis correspond to the highest resolution shell. Rfree was calculated for 5% of the 
reflections randomly chosen for each data set. (*) MV  (methyl viologen) was 14 mM, Dith. (sodium 
dithionite) was 14 mM, potassium nitrate was 100 mM and sodium azide was 100 mM. This 
structure was not fully refined. 
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at the end of the diffraction experiment. By avoiding this data, we lowered the contribution 
from possible radiation damage to the model, but observed the same electron density for 
cysteine 388 and 784 in these structures.  
3.4 THERMAL SHIFT ASSAYS 
To study ligands interaction with the NapAB protein we performed thermal shift 
assay experiments, using several substrates, inhibitors and reducing agents. We started 
by using the standard protocol available in the Laboratory (with a final protein 
concentration of 2 µM). However, the initial results showed that this concentration was too 
low to obtain a significant noise free signal and we decided to use 16 µM instead as the 
final concentration of NapAB. Because the fluorescence intensity is dependent on the 
amount of hydrophobic amino acid residues interacting with the dye, this might be a 
consequence of the protein having few hydrophobic residues as in the case of small 
globular proteins. However, this is not expected from NapAB from C. necator since it is a 
110 kDa globular protein (NapA – 90 kDa and NapB – 17 kDa). 
 The TSA profile of NapAB is represented in Figure 3.9.a-b in the native state and 
in the presence of several ligands, such as TCEP, methyl viologen, sodium dithionite, 
potassium nitrate, sodium nitrite and potassium perchlorate (in all cases triplicates were 
made). The denaturation profile of the protein shows a multi-peak TSA profile starting from 
45 ºC onwards and we considered 51 ºC as the NapAB melting temperature or Tm. In the 
presence of both nitrate (KNO3, green) and nitrite (NaNO2, blue) the results show an 
altered denaturation profile of NapAB (Figure3.9 a).  When using 14 mM of sodium 
dithionite there are no significant changes in the denaturation profile NapAB (neither when 
using other concentrations – data not shown). The TSA shows that using a 15 mM of TCEP 
results in a significant denaturation of the protein, indicated by the high fluorescence 
intensity in the beginning of the assay (Figure3.9 b). When using a lower concentration of 
TCEP (5 mM) the profile changes are not significant different form the results obtained 
without TCEP.  
These results from NapAB incubated with TCEP at 15 mM were unexpected. In the 
crystallographic assays when using 14 mM TCEP it was noticed that it decreased the 
number of multiple crystals. Even more, the best overall crystal condition was using TCEP 
incubations with nitrate. However, this is probably explained by the difference of the 
TCEP/NapAB ratio, whereas in the crystallization assays it is about 90, for the TSA it 
reaches 940. 
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Most of the ligands tested resulted in minor alterations in the NapAB denaturating 
profile. This is visible when we compare the various melting curves (Figure 3.9 c-f) and 
observe no significant changes in the Tm for the various ligands tested. This shows that 
the protein is very stable in the purification buffer used (300 mM Tris-HCl pH 7.6) and that 
no significant structural changes are expected upon ligand binding in the crystal). The 
presence of several different peaks in the NapAB profile might be due to different melting 
temperatures of the corresponding NapA and NapB subunits accompanied by different 
melting temperatures for specific NapAB domains. More studies are required to verify this 
hypothesis, including controls using an inactive form of the protein or the two subunits 
(NapA and NapB) isolated from each other. 
Figure 3.9: Comparison of various TSA results. 
a) and b) show the native NapAB TSA profile and with potassium nitrite, potassium nitrate, 
potassium perchlorate, dithionite and TCEP; c-f) the NapAB melting curve using different potassium 
nitrate, TCEP, dithionite and DTT concentrations. 
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3.5 ISOTHERMAL TITRATION CALORIMETRY 
To try to obtain the thermodynamic parameters of the nitrate interaction with NapAB 
an ITC assay was carried out injecting TCEP and potassium nitrate into the reaction cell 
containing TCEP, potassium nitrate and Nap. In the control assay, NapAB was excluded 
from the reaction cell. We chose to test TCEP as the reducing agent because in the co-
crystallizations structures obtained with TCEP a nitrite molecule was found near the active 
site channel, suggesting that TCEP might activate Nap. The fact that TCEP improved the 
crystallization of NapAB also contributed to this decision.  
The ITC results (Figure 3.10) show that no nitrate-NapAB interaction or catalytic 
activity was detected. It might be that NapAB requires a suitable reducing agent not only 
for catalysis, but also for allowing nitrate-NapAB interactions. If TCEP is unable to pre-
activate Nap, this would explain why neither catalysis nor nitrate-NapAB interaction was 
detected. To test this hypothesis, we performed a qualitative NapAB activity assay using 
TCEP instead of dithionite and methyl viologen. Interestingly we could not observe the 
development of a pink color corresponding to the presence of nitrite in solution, indicating 
that no nitrite was produced when using TCEP as the reductive agent and corroborating 
the ITC results that TCEP is not able to activate Nap. However, the crystal structures 
where nitrite was found were obtained using TCEP and nitrate co-crystallized, and this 
remains as a puzzling question. 
More ITC experiments are required to better understand if ITC is a suitable technique 
to study NapAB reaction kinetics. So far there is no evidence in the literature that these 
assays have been performed on other bacterial nitrate reductases. The only study 
Figure 3.10: Comparison of an ITC assay to the control. 
In the reaction cell was 0.2 µM NapAB and 17.5 µM TCEP (red line) and the control (green line) 
was absent of NapAB. Six potassium nitrate (5 mM) injections of 15 µL were made into the reaction 
cell, varying the potassium nitrate concentration in the reaction cell from 74 µM to 412 µM. 
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available refers to the eukaryotic NR where the authors study the Moco insertion into the 
apoenzyme [54]. Testing sodium dithionite or methyl viologen as reducing agents and 
electron donors, by mimicking the activity assays might be good starting choices for future 
assays. 
3.6 MICROSCALE THERMOPHORESIS 
In the MST assays, we initially tested two different labelled NapAB concentrations 
(4.4 µM and 44 µM) from which we could observe that the signal provided from the 44 µM 
sample was more adequate. Protein absorption to the capillary walls was observed when 
using the standard capillaries, but this problem was overcome when using the Premium 
Coated Capillaries as shown in Figure 3.11.b (NanoTemper Technologies). 
 We started by studying NapAB interactions with nitrate without the presence of any 
reducing agents. The first binding affinity test used potassium nitrate ranging in 
concentrations from 500 mM to 0.2 mM (Figure 3.11.a). This test seemed to detect nitrate 
interaction with Nap, suggesting that higher nitrate concentrations would be required for 
adequate Kd calculation. We also tested potassium nitrite in similar concentrations but a 
loss in reproducibility was observed for all assays.  
 The first reproducibility problems concerned the lack of fluorescence homogeneity 
between capillaries, being proportionally higher with ligand concentrations. Within a couple 
assays, protein aggregation indicators became noticeable in the MST traces profiles. This 
is observable by the fluorescence regularity lack during the Infra-Red laser on stage 
(Figure 3.11.d). 
Because the labelled NapAB sample showed aggregation, we centrifuged the 
sample prior to each assay at 9000 g for 10 minutes, and as a result the MST assays 
reveled a small degree of reproducibility, mainly in the MST traces. However, the capillary 
scans remained dubious. Because of this, we proceeded by testing if nitrate was non-
specifically inducing fluorescence through the SDS denaturation test protocol provided by 
NanoTemper technologies.  
We noticed that potassium salts are incompatible with the SDS test and so, we 
proceeded using sodium nitrate and later compared the results to verify that no significant 
differences were found between using potassium or sodium nitrate in the binding affinity 
tests. Ligand-dependent fluorescence changes can be originated from ligand-dependent 
protein absorption to labware (for example pipette tips), in which case detergent addition 
could help to solve the problem. After the SDS test confirming ligand-dependent 
fluorescence changes, we added Tween 20 detergent to the labelled NapAB sample to a 
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final concentration of 0.05 %. By using this new approach (sample centrifugation and 
detergent usage) before the assays resulted in higher rates of reproducibility (Figure 
3.11.c). 
We tested different nitrate concentrations and observed that potassium and sodium 
nitrate provided similar results. However, in each assay the binding curve always 
suggested that higher ligand concentrations were required because too few dose response 
points were observable in the bound state. We experimented a few sodium nitrate 
concentrations and observed the same binding curve profile in every case, after which we 
stopped the MST experiments. 
We concluded that the nitrate concentrations and calculable Kd ranges from those 
experiments were not biologically relevant. The Kd calculations were automatically 
estimated through the Monolith NT 1.115 software, which assumed one binding site for 
each ligand. In case this assumption is wrong for the NapAB study, this could explain the 
Kd ranges. However, the constant ligand-dependent fluorescence increase in the laser on 
stage, even at high nitrate concentrations contradicts this hypothesis. If the software would 
be responsible for the misleading Kd results, it would be expected that the ligand-
dependent fluorescence increase would stop before reaching non-biologically relevant 
numbers. 
Potassium and sodium nitrate behavior as salts, can explain the gradual increase in 
fluorescence. The MST signal change depends on three main factors: molecular size, 
charge and hydration shell. The titration of sodium and potassium nitrate, increasing the 
ionic strength in the capillaries might be responsible for the increase of fluorescence in the 
MST traces. To validate this hypothesis, a control test using different salts not expected to 
interact site-specifically with NapAB should be used in future assays. 
 During the experiments, we did not test NapAB with reducing agents. If NapAB is 
inactive without reducing agents, enzyme-substrate favorable interactions might be scarce 
when comparing to the active enzyme. Assays using combinations of dithionite and methyl 
viologen could be compared to the non-reduced NapAB results to verify such hypothesis. 
Experiments mimicking the activity assays in which Nap, nitrate and methyl viologen 
concentrations would be maintained, while titrating dithionite could provide valuable insight 
into the reaction mechanism. This method could avoid the concentration-dependent 
increase in fluorescence caused by nitrate, if it is a byproduct of the ionic strength 
escalation. The ionic strength in the capillaries should not significantly change during 
catalysis because, the substrate and product are both monovalent ions. 
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For future MST experiments, a strong control would be desirable. Proteins of 
similar sizes not related to nitrate, nitrite and the reducing agents dithionite or methyl 
viologen could be used. The ideal control would however be an inactivated NapAB protein. 
Figure 3.11: Summary of the microscale thermophoresis assays. 
Dose response charts are calculated from the corresponding MST traces blue (laser off) and red 
(laser on) values. a) MST results for a potassium nitrate titration starting at 500 mM. The dose 
response chart shows the majority of data points in a unbound stage and few in the bound stage, 
suggesting at the time higher potassium nitrate concentrations should be used. In the capillary 
scans chart a 9% signal variation is shown. b) a capillary scan comparing Nap samples in normal 
or premium capillaries. In the first case capillary wall adhesion is observed. c) MST results for a 
sodium nitrate titration starting at 1500 mM, detergent was used to a final concentration of 0.05% 
and the samples were centrifuged prior to the assay. The dose response chart shows a similar 
result as in a). In the capillary scans chart to 6% variation is shown. d) MST results for a sodium 
nitrate titration starting at 1500 mM, without using any detergent concentration or centrifuging prior 
to the assay. The capillary scans a signal variation of 67% is shown and in the MST traces signs of 
protein aggregation are observable in the laser-on region. 
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4 CONCLUSIONS AND FUTURE PERSPECTIVES 
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During the course of this work, a total of 125 crystals were prepared and sent to 
various synchrotron beamlines, aiming to obtain a reaction mechanism intermediary 
structure of NapAB from C. necator. Complementing the X-Ray Crystallography study, we 
used three other techniques: TSA, ITC and MST. Although we did not obtain clear 
evidence for the reaction mechanism, we further advanced the case in study and paved 
the way for future experiments by optimizing the NapAB crystallization condition and the 
MST sample preparing.  
During this work, we discovered and optimized a novel crystallization condition for 
NapAB from C. necator. The crystals grew with a high degree of reproducibility to 
approximate dimensions of 0.3 x 0.2 x 0.2 mm. The co-crystallization with potassium 
nitrate strongly improved the crystallization process, increasing the crystal size and 
inhibiting the nucleation event – which was commonly the bottleneck of the crystallization 
assays. Interestingly, although TCEP induced the nucleation event, when used in 
combination with potassium nitrate if further improved the crystals, significantly lowering 
the number of multiple crystals. 
Coelho and co-workers obtained a partially reduced NapAB structure, where the 
coordinating Cys was found in two alternate conformations, one of which unbound from 
the Mo. This posed important implications on the discussion of the reaction mechanism 
for these enzymes. The structure was obtained using dithionite as the reducing agent and 
was the only such structure until now. In this work, we obtained similar electron density at 
the Mo coordinating cysteine for dithionite and TCEP co-crystallized NapAB. This 
corroborates the cysteine alternate conformation and therefore, the proposed mechanism 
suggests that TCEP is also suitable as a reducing agent to activate NapAB.  
TCEP was used in the co-crystallization assays as well as in ITC and in TSA 
experiments. The TCEP and potassium nitrate co-crystallized NapAB structures show an 
alternate conformation of the Mo coordinating cysteine but also, a nitrite molecule at the 
substrate channel 12 Å away from the active site. This means that we have captured the 
structure of an intermediate state with the Cys partially displaced and the product nitrite 
on the substrate channel held by four H bonds. This further corroborates that TCEP is 
suitable to activate NapAB and provide the necessary reductive potential.  
However, contrary to this evidence the ITC assays detect no catalysis or NapAB-
nitrate interaction and the activity assays show no color development corresponding to the 
presence of nitrite in solution. This seems to suggest that TCEP is unable to activate 
NapAB when used as the single electron donor, making this a puzzling question. Possibly 
the reaction rate when using TCEP as the single electron donor is too low for detection by 
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the activity assays. More ITC assays would help clearing this question. ITC assays testing 
sodium dithionite and methyl viologen as the electron donors should provide ITC signal 
correspondent to catalysis; otherwise, it becomes clear that ITC is not adequate for the 
study of NapAB. 
Nitrite was also found in sodium dithionite and potassium nitrate co-crystallized 
NapAB. In the activity assays, the development of a pink color corresponding to the 
presence of nitrite is observable. The spectrum of NapAB with sodium dithionite show a 
Soret band shift from 410 to 420 nm and the appearance of two bands at 550 and 522 nm 
corresponding to of c-type heme reduction of NapAB. This strongly suggests that dithionite 
can activate NapAB when used as the single electron donor, even if at a slower rate that 
when used in combination with methyl viologen – the electron donor in the activity assay.  
When methyl viologen co-crystallized NapAB crystals were introduced to soaking or 
cryoprotectant solutions, breaches were immediately formed. Often, the same crystals 
recovered from the breaches in a few hours, and even crystals fast-frozen (with the 
breaches) and sent to the synchrotron beamlines were there observed to lack any breach. 
The unit cell of one such crystal is different from all other unit cells obtained in this work, it 
has the cell constants of a = 141.6 Å, b = 83.2 Å, c = 97.3 Å and β = 101.3° in contrast to 
a = 135 Å, b = 71 Å, c = 114 Å and β = 110°. Moreover, NapAB crystals soaked in methyl 
viologen and then soaked in sodium dithionite with nitrate did not diffract, whereas the 
NapAB co-crystallized with methyl viologen which were then exposed to the same 
soakings did diffract up to 2.3 Å. The crystal cracking, the differences in unit cells and this 
difference in soaking results make it plausible that methyl viologen affects the crystal 
packing of NapAB. More co-crystallization assays using combinations of methyl viologen 
and sodium dithionite (mimicking the activity assays) might provide new insight on the 
reaction mechanism of NapAB. 
Although MST did not provide any new insight, we did optimize the study of NapAB 
through MST. More MST and ITC assays may provide valuable information on this case 
study. Testing different combinations of sodium dithionite, sodium nitrate, methyl viologen 
and TCEP are interesting first choices for future experiments. Due to the NapAB crystal 
size using the novel crystallization condition (a 1,0 mm crystal was obtained), neutron 
diffraction might be a useful technique for the study of the reaction mechanism. Since 
proposed reaction mechanism involves the transfer of two protons (in two separated steps) 
to the active site that are released as water, information about them might become 
invaluable. Time-Resolved X-Ray Crystallography is also a technique with great potential 
for elucidating the reaction mechanism of NapAB. After optimization of adequate NapAB 
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micro-crystals, various reaction mechanism intermediary structures along the catalysis are 
possible to obtain using this technique. If such structures are obtained, this technique may 
alone elucidate the reaction mechanism of NapAB. 
From a personal perspective, this dissertation has completely fulfilled my 
expectations. It provided me extensive practical experience and a solid X-Ray 
Crystallography background, fulfilling its didactic role. Considering that X-Ray 
Crystallography is a technique of great potential and so vast, I am happy to consider myself 
a young novice crystallographer, with a satisfying understanding of the field and aiming to 
know more. 
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